Regulation of Neuronal mRNA Localization by Exclusion by Martinez, Jose Carlos
Regulation of Neuronal mRNA Localization by Exclusion 
José C. Martínez 
Submitted in partial fulfillment of the  
requirements for the degree of Doctor of Philosophy 
under the Executive Committee 




José C. Martínez 
All rights reserved 
ABSTRACT 
Regulation of Neuronal mRNA Localization by Exclusion 
José C. Martínez 
Intra-axonal protein synthesis is important for the proper wiring of the nervous system and can have 
restorative or pathogenic effects in response to nerve injury and neurodegenerative stimuli. The set 
of axonally translated transcripts, the axonal translatome, is regulated through the control of mRNA 
localization, stability, and translation. Targeting the axonal translatome could result in the 
development of novel therapies for the treatment of neurological disorders. Yet, there are gaps in 
our understanding of the selective mechanism regulating the specific localization of mRNAs into 
axons. Currently, axonal localization of transcripts is understood to be controlled by the presence of 
sequence elements that direct axonal transport. In an attempt to identify novel localization motifs, I 
found that a well-known motif corresponding to the Pumilio Binding Element (PBE) is significantly 
depleted in axonally enriched mRNAs. Moreover, I found this element to be highly informative of 
axonal mRNA localization and translation across different neuronal types and developmental stages 
suggesting that it is a highly conserved regulatory motif. I found Pum2 neuronal expression and 
subcellular localization to be highly consistent with the way the PBE predicts mRNA regulation. I 
then demonstrated that interfering with Pum2 function results in increased axonal localization of 
PBE containing mRNAs. Finally, Pum2 downregulation was associated with gross defects in axonal 
outgrowth, branching, and regeneration. Altogether, this data suggests that Pum2 regulates axonal 
mRNA localization through an exclusion mechanism that is important during neuronal 
development. 
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Chapter 1. General Introduction 
Randomness is an inherent property of all molecular interactions. Living organisms 
continuously rely on a significant number of stochastic molecular processes while achieving precise 
outcomes with very little error. As this comes at a tremendous energy cost, given limited resources, 
how are biological organisms not only able to exist but to evolve and flourish? A simple and elegant 
solution is to create distinct subcellular compartments which minimizes the noise generated by 
molecular processes and their effect on the whole system. Such cellular compartmentalization has 
been proposed as a passive noise filtering mechanism in biological systems (Stoeger et al., 2016). 
Although initially overlooked in biology, passive noise filtering by compartmentalization is very 
advantageous since it is highly efficient and scalable at low energy cost. One prominent biological 
example is passive noise filtering in transcript abundance by nuclear compartmentalization (Battich 
et al., 2015; Stoeger et al., 2016). 
 Transcription, which takes place in the nucleus, occurs in “burst” which leads to stochastic 
fluctuations in transcript abundance. Cytoplasmic transcript abundance has been observed to be 
stable and tightly regulated. Battich et al. (2015) found that regulation of nuclear retention and export 
is responsible for reducing the stochastic noise resulting from bursty transcription by a factor of 
three to four. Importantly, this comes at no additional energy cost for the cell, which would be 
significant if an active filtering mechanism, such as controlling mRNA degradation, was 
predominantly utilized.  An advantageous consequence of compartmentalization is reduced cell-
intrinsic phenotypic variability due to noise from stochastic transcriptional events (Battich et al., 
2015). In turn, this provides benefits for multicellular organisms where extrinsic factors as well as 
spatial positioning drive phenotypic variability. 
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The evolution of complex molecular processes is thus aided by compartmentalization 
through increased cellular regulatory control, conferring cells an enhanced ability to specialize. 
Therefore, it is not surprising that compartmentalization is thought to play an essential role in the 
development of multicellular organisms and systems. One such striking system and the focus of this 
thesis work is the nervous system. Santiago Ramón y Cajal (1879-1930) was among the first to 
describe the complexity and diversity of nerve cells. In one of his drawings, it is easy to appreciate 
the extensive compartmentalization of a pyramidal neuron (Figure 1).  These cells do not only 
contain a cytoplasm and nucleus, but processes that extend beyond the cell body called neurites. 
There are two distinct types of neurites: dendrites and axons. Dendrites are short and abundant, 
containing even smaller compartments called dendritic spines, while there tends to be only a single 
axon capable of extending long distances. Interestingly, both of these compartments are capable of 
localized protein synthesis in response to diverse stimuli and independently from somatic input. The 
functional role of localized protein synthesis has been underscored in the context of nervous system 
development, maintenance, and disease. Thus, the mRNA and protein composition of dendrites and 
axons must be tightly regulated, leading to the question of how selectivity and fidelity are achieved in 
establishing and preserving the functional and molecular differences between these compartments?  
 In work presented here, I will try to address this question with a focus on how axonal 
mRNA localization and translation are regulated in developing neurons. Since local mRNA 
translation is intimately connected to mRNA localization, most of my work will focus on how 
neurons control the later process. Unlike in nuclear compartmentalization, axons are not physically 
separated from the rest of the cell by a membrane. Although the axon initial segment has been 
shown to be capable of filtering transport of specific proteins and their cargo into the axon, its role 
in the regulation of mRNA entry and transport is less clear. Particularly puzzling is what determines 
the identity of the set of mRNAs that populate the axon. Since this has to be achieved with high 
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precision, a filtering mechanism should be in place. The hypothesis tested in this work is that such a 
filtering system exists and that it can at least be partially exemplified by the interactions of a 
somatically localized RNA binding protein and its target mRNAs. In the following sections, I give a 
comprehensive background and review of the research in the main areas that helped create and 
address this hypothesis: 1) local translation, 2) mRNA localization, 3) RNA binding proteins.  
Figure 1.1: Drawing of Pyramidal Neuron. Representation of a pyramidal neuron by 
Santiago Ramon y Cajal demonstrating the extensive compartmentalization of this cell. 
Several dendrites with branches and dendritic spines are observed. A single axon extending 
downwards is remarkably different since it does not have any spines. 
3
1.1 Local translation  
Compartmentalization is at least partly responsible for neurons' ability to carry out complex 
signal processing and integration. Neurons are thus presented with the challenge to establish and 
maintain morphologically and functionally distinct compartments. To accomplish this, they must 
precisely regulate the local proteome with high spatiotemporal precision. Intuitively then, local 
translation is an elegant solution to the problems presented by local proteome homeostasis 
regulation (Jung et al., 2012, 2014). Local protein synthesis offers several advantages over 
transporting proteins synthesized elsewhere. First, the most obvious benefit is that locally 
synthesized proteins are produced where and when needed. This allows neurons to respond quickly 
and precisely to localized stimuli which can at times occur very far from the somatic compartment. 
Aside from avoiding a delayed response, it is also more energy efficient as it does not require 
coordinated active protein transport. Moreover, proteins produced on-site might be differentially 
post-translationally modified as well as interact with otherwise uncommon molecular partners. On 
the following sections, I will review the evidence for the importance and role of local translation in 
neuronal development, maintenance, and disease. 
 
1.1.1 Local protein synthesis in dendrites 
A substantial amount of work in neuroscience has demonstrated the role of protein synthesis 
in long-term memory formation, but only in the past two decades has that work focused on the 
dendrite as the site of synthesis (Sutton and Schuman, 2006). As early as 1965, Bodian observed for 
the first time that ribosomes are present in proximal dendrites (Bodian, 1965). To which he 
hypothesized “…that selective establishment of synaptic contacts may be determined by specific 
proteins synthesized at the synaptic membrane of the receptive neuron.” Seventeen years later, 
Steward and Levy further characterized this phenomenon by quantitatively describing the presence 
4
of polyribosomes at the base of dendritic spines (Steward and Levy, 1982). Subsequently, a series of 
studies demonstrated that radiolabeled amino acids are incorporated into proteins in synaptic 
enriched fractions as well as in dendrites separated from the soma (Rao and Steward, 1991; Weiler 
and Greenough, 1991; Torre and Steward, 1992). Moreover, time course analysis revealed that the 
appearance of this newly synthesized proteins at synaptic sites was too fast to be accounted for by 
transport (Feig and Lipton, 1993; Steward et al., 1991). 
 The first evidence of the functional role for local translation in dendrites was provided by 
Kang and Schuman in 1996 when they showed that neurotrophin dependent dendritic protein 
synthesis was required for long-lasting enhancement of synaptic transmission (Kang and Schuman, 
1996). Soon thereafter several studies provided more supporting evidence for the role of dendritic 
protein synthesis in the establishment of different forms of synaptic plasticity (Cracco et al., 2005; 
Huang and Kandel, 2005; Huber et al., 2000; Martin et al., 1997; Miller et al., 2002; Vickers et al., 
2005) as well as in synapse formation (Sebeo et al., 2009). The study by Miller et al. (2002) stands out 
as the first demonstration of the importance of local translation in vivo. Here, Miller generated a 
mouse model where the dendritic localizing element of CaMKIIα was removed from the 3’UTR of 
the corresponding transcript. This resulted in an almost exclusive somatic localization of CaMKIIα 
mRNA and significantly reduced expression of its protein in dendrites. These mutant mice had 
significant defects in learning and memory. An et al. (2008) provided another critical example that 
also highlights the role of the 3'UTR in regulating the localization and translation of a mRNA in vivo.  
First, they reported differences in the localization of the long and short 3’UTR isoforms of BDNF, 
with the long 3’UTR driving the localization of BDNF mRNA into dendrites. Then, they generated 
a genetically modified mouse where the long 3’UTR isoform of BDNF was truncated. BDNF 
localization and translation in dendrites was impaired in these mice. Moreover, they showed defects 
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in pruning and enlargement of dendritic spines with selective impairment in LTP in dendrites but 
not soma (An et al., 2008).   
 Lastly, an important question remained on whether local translation also played a role during 
ongoing synaptic activity and not just under strong stimulated conditions. Sutton and colleagues 
explored this issue by measuring the effects of inhibiting spontaneous neurotransmission in local 
dendritic segments (Sutton et al., 2004, 2006). Inhibiting these minis let to an increase in local 
protein synthesis with a resulting stabilizing effect on synaptic transmission. 
 
1.1.2 Local protein synthesis in axons 
Evidence for axonal protein synthesis dates back to the 1960s (Edström and Sjöstrand, 1969; 
Giuditta et al., 1968; Koenig, 1967). It was met with early skepticism due to a later finding that failed 
to demonstrate the presence of rRNA in axons (Lasek et al., 1973). Moreover, an electron 
microscopy study of adult rats found that polysomes were restricted to the axon initial segment and 
not detectable in the axon shaft of CNS neurons, thus questioning whether axonal translation could 
occur in adult axons at all (Steward and Ribak, 1986). On the contrary, ribosomes had been 
identified in developing axons earlier (Bunge, 1973; Tennyson, 1970; Yamada et al., 1971) and, 
unlike in cultured conditions, it was found that ribosomes did not form polysomes in axons in vivo, 
suggesting a predominance for monosomal translation that is spatiotemporally restricted (Jung et al., 
2012). Additionally, biochemical data was accumulating that confirmed the presence of rRNA, 
mRNAs, and translating polysomes in invertebrate axons (Giuditta et al., 1980, 1986, 1991). 
Subsequently, immunohistological studies identified the presence of ribosomal mRNAs and proteins 
in mature PNS axons in the form of intermittently scattered plaques near the plasma membrane 
(Koenig and Martin, 1996; Koenig et al., 2000; Kun et al., 2007).  This finding may explain why it 
was initially difficult to identify the presence of ribosomes in axons utilizing conventional 
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ultrastructural criteria (Jung et al., 2012). Finally, the greatest evidence for axonal protein synthesis 
came from experiments utilizing metabolic labeling to show that axons are capable of mRNA-
dependent protein synthesis in the absence of soma (Eng et al., 1999; Koenig, 1967, 1991; Koenig 
and Adams, 1982; Tobias and Koenig, 1975a, 1975b). Altogether, these studies demonstrated the 
capacity of axons for localized protein synthesis, yet they also indicated that the protein synthesis 
machinery and local translation regulation might function differently from the way it was understood 
in the somatic and dendritic compartments.  
Although axons had been shown to be capable of local protein synthesis, its functional role 
remained a mystery. In fact, an early study found that inhibiting local protein synthesis did not 
interfere with axon elongation (Eng et al., 1999). The first demonstration of the functional 
significance of axonal protein synthesis came from its identified role in mediating axonal growth 
cone chemotropic responses to Netrin-1 and Sema-3A (Campbell and Holt, 2001). In this seminal 
work, soma-less growth cones were shown to be able to turn towards netrin-1 gradients and away 
from Sema-3A gradients. Application of these guidance cues to such axons induced protein 
synthesis through mTOR activity. In turn, these chemotropic responses were abolished by inhibition 
of mTOR or protein synthesis directly. This effect was shown to be specific for these cues and 
mediated by local protein synthesis since the application of lysophosphatidic acid (LPA) in turn 
resulted in growth cone collapse independently of local mTOR activity nor protein synthesis. Since 
then, there has been growing evidence that axons can respond to a variety of signaling molecules 
such as: netrin-1 (Hengst et al., 2009; Leung et al., 2006; Tcherkezian et al., 2010; Yao et al., 2006), 
semaphorin-3a (SEMA3A) (Balastik et al., 2015; Campbell et al., 2001; Deglincerti et al., 2015; 
Nédelec et al., 2012; Wu et al., 2005), slit-2 (SLIT2) (Piper et al., 2006), engrailed 1 and 2 (EN1 and 
EN2) (Alvarez-Fischer et al., 2011; Brunet et al., 2005; Wizenmann et al., 2009), nerve growth factor 
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(NGF) (Cox et al., 2008; Gracias et al., 2014; Hengst et al., 2009; Villarin et al., 2016),  and brain 
derived neurotrophic factor (BDNF) (Yao et al., 2006). 
 An interesting observation from these studies is the ability of axons to control determined 
growth cone behaviors such as turning or collapse, by translating only very specific mRNAs, in 
response to distinctive cues, even though these signals nonspecifically engage the whole translational 
machinery generally through mTOR pathway activation. For example, in response to a gradient of 
attractive cues such as NTN1 and BDNF, β-Actin is locally and asymmetrically synthesized in the 
side of the growth cone closest to the gradient (Leung et al., 2006; Yao et al., 2006).  In this scenario, 
blocking β-Actin synthesis or even the asymmetric localization of its mRNA in the growth cone is 
enough to prevent attractive growth cone turning. On the contrary, repulsive cues such as SLIT2 
and SEMA3A induce the local synthesis of actin disassembly promoting factors cofilin (Piper et al., 
2015) and RhoA (Wu et al., 2005) respectively, without inducing β-Actin synthesis. Moreover, 
interfering with axonal translation of RhoA is sufficient to block SEMA3A induced growth cone 
collapse, demonstrating the specificity of this pathway (Wu et al., 2005). 
The prior examples demonstrated the role of local axonal translation in regulating local 
growth cone responses. Recently, there has been accumulating evidence to suggests that local 
protein synthesis can exert a broader effect on neuronal health and function through retrograde 
signaling of locally produced factors from the periphery to the soma (Andreassi et al., 2010; Baleriola 
et al., 2014; Cox et al., 2008; Ji and Jaffrey, 2012; Villarin et al., 2016).  NGF application to axons 
alone is sufficient to promote DRG survival in a protein synthesis-dependent manner (Cox et al., 
2008). This is mediated by the axonal synthesis and retrograde transport of the transcription factor 
cyclic AMP responsive element-binding protein (CREB) in response to NGF stimulation. In fact, 
somatically derived CREB does not mediate NGF-induced cell survival. This was the first evidence 
that axons could regulate neuronal homeostasis through the production of transcription factors. In 
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another example, it was found that trigeminal ganglia subtype specification was governed by the 
local translation and retrograde transport of SMAD1/5/8 in response to BDNF and BMP4 axonal 
signaling (Ji and Jaffrey, 2012). Very interesting is the finding that axonal application of β-amyloid 
(Aβ) leads to neuronal death mediated by axonal synthesis and retrograde transport of activating 
transcription factor 4 (ATF4) (Baleriola et al., 2014). It once again highlights the specificity of 
axonally derived responses to local stimuli by demonstrating that axons are not only capable of 
promoting neuronal surviving but also death. It also linked axonal dysfunction through local protein 
synthesis to neurodegeneration.   
Although initial reports had found little evidence for translation in mature axons, further 
studies into the axonal response to nerve injury demonstrated increased local protein synthesis to be 
necessary for regeneration (Hanz et al., 2003; Verma et al., 2005; Zheng et al., 2001). Moreover, it 
seemed that the ability of axons to regenerate was intrinsically associated with their translational 
capacity as modulating mTOR activity through PTEN inhibition, both locally and globally, resulted 
in increased regeneration (Christie et al., 2010; Park et al., 2008).  Mechanistically, axonal injury 
results in retrograde signaling of locally synthesized transcription factors that modulate neuronal 
gene expression programs to favor axon regeneration (Michaelevski et al., 2010). For example, upon 
axonal injury DRG axons locally synthesize and retrogradely transport STAT3 to the nucleus where 
it is required to promote a regenerative program (Ben‐Yaakov et al., 2012). Moreover, axon injury 
also modulates retrograde transport itself through the local synthesis of Ran-specific GTPase-
activating protein (RANBP1) (Yudin et al., 2008) and importin-β1 (Hanz et al., 2003), which in turn 
associate with and regulate the entry of proteins containing nuclear localization signals (NLS) into 
the nucleus. Finally, nerve injury also induces the local translation of vimentin which in turn 
promotes the retrograde transport of phosphorylated Erks (pErks) which regulate complex signaling 
pathways (Perlson et al., 2005).   
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 Finally, Shigeoka and colleagues recently produced the best evidence for mature axonal 
translation and, most complete understanding of local translation in developing axons in a living 
organism (Shigeoka et al., 2016a). They developed an axon-TRAP-RiboTag mouse which allows 
specific isolation of ribosome-bound mRNAs in the distal compartment of retinal ganglion cells 
(RGC) axons in vivo. Using this approach, they characterized the axonal translatome of RGC axons 
at different developmental stages (E17.5, P0.5, P7.5, and adult). They found a dynamic set of 
mRNAs is translated at each developmental stage matching the axon specific function of that stage. 
For example, during the embryonic stage a significant number of mRNAs associated with “axon 
extension” are being synthesized, while at the adult stage there is a switch for the synthesis of 
mRNAs associated with “synaptic transmission”. Finally, they identified a set of motifs linking 
alternative splicing with isoform specific transcript translation in axons.  
 
1.2 Neuronal mRNA localization 
Although it has not always been recognized as such, increasing evidence strongly suggests 
that mRNA localization is a primary determinant of protein localization (Gáspár and Ephrussi, 
2017a; Jung et al., 2014; Moor et al., 2017; Zappulo et al., 2017a). For example, during Drosophila 
embryonic development up to 71% of transcripts were found to be localized (Lécuyer et al., 2007). 
While in Drosophila ovarian cells a more modest 22% of mRNAs showed a subcellular localization, 
their localization was dynamically regulated across development, and it was cell type specific (Jambor 
et al., 2015). Similarly, a broad look at mRNA localization in hippocampal neurons found over 2000 
mRNAs (about 30% of the total) to be localized to dendrites and or axons. This highly regulated and 
asymmetric localization of mRNAs is not unique to developing organisms or complex eukaryotic 
cells since it has been found even in bacteria (Keiler, 2011). In the following sections, I will focus on 
mRNA localization in neurons, with an emphasis on axonal mRNAs. 
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1.2.1 ‘Zipcode’ localizes mRNA 
Based on several studies of mRNA localization in dendrites it was already widely known that 
elements contained in the 3’UTR of mRNAs were responsible for directing subcellular localization 
(Kuhl and Skehel, 1998). Several good examples, some of which I mentioned earlier in regards to 
localized translation in dendrites, include CaMKIIα (Imaizumi et al., 2000; Mayford et al., 1996), 
BDNF (An et al., 2008) and Arc (Kobayashi et al., 2005). This notion has been extended to axonal 
mRNA localization by several groups (Aronov et al., 1999; Ben‐Yaakov et al., 2012; Merianda et al., 
2013, 2015; Vuppalanchi et al., 2010; Wu et al., 2005; Yudin et al., 2008). Perhaps, the best 
characterized cis-acting element driving axonal mRNA localization is in the β-Actin 3’UTR.  Actin 
isoforms were found to localize differentially within neurons, β-Actin localizes to axons and, γ-Actin 
localizes to the soma (Bassell et al., 1998).  The axonal localization of β-Actin was found to be 
increased upon neurotrophin stimulation (NT-3) and to be dependent on its 3'UTR (Zhang et al., 
1999, 2001). Specifically, the association of the Zipcode Binding Protein 1 (ZBP1), with an element 
termed the ‘zipcode’ in the β-Actin 3’UTR was responsible for the axonal localization of this 
transcript (Willis et al., 2011; Zhang et al., 2001). Moreover, transgenic expression of a mRNA with 
the 3'UTR of β-Actin but not γ-Actin drives its localization to axons in vivo (Willis et al., 2011). 
Finally, the stoichiometry of ZBP1 and β-Actin mRNA has to be tightly regulated since the 
introduction of an exogenous construct with the β-Actin 3’UTR, or the knockdown of ZBP1, 
results in a significant decrease in β-Actin mRNA localization and translation in axons with 
physiological and morphological effects in axon growth (Donnelly et al., 2011, 2013).  
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1.2.2 Axonal mRNAs are dynamic 
As it became more technically feasible, researchers expanded the repertoire of axonally 
localized mRNAs. The axonal mRNA population was found to be highly dynamic by responding to 
extrinsic as well as intrinsic cues. Application of a variety of neurotrophins as well as repulsive 
molecules to regenerating DRG adult axons led to a differential effect in the localization of a pool of 
50 mRNAs (Willis et al., 2007). The axonal mRNA content of axons in response to NGF was 
further characterized through SAGE analysis, revealing the presence of hundreds of mRNAs (over 
11,000 tags) (Andreassi et al., 2010). Here, Impa1 was found to be the most enriched axonal mRNA 
and, its localization in axons was driven by an element in its 3’UTR much similarly to β-Actin. The 
development of a microfluidic device allowed for the isolation of matured CNS axons for the first 
time and, coupled with microarray analysis led to the identification of more than 300 mRNAs in 
axons (Taylor et al., 2005, 2009). This axonal mRNA population was altered upon axotomy (Taylor 
et al., 2009). Cell intrinsic changes in the axonal transcriptome were found during development from 
the observation that embryonic and adult axons/growth cones differ in their mRNA content (Gumy 
et al., 2011; Zivraj et al., 2010). Using microarray analysis, the number of mRNAs identified was 
2627 in embryonic and 2924 in adult axons, with about 1400 overlapping genes which mostly 
encoded for ‘mitochondria’ and ‘protein synthesis’ gene enrichment categories suggesting that a core 
set of mRNAs might be required for general axon function (Gumy et al., 2011). Finally, comparison 
of growth cone vs whole axons found a distinct set of mRNAs enriched at the growth cone 
suggesting that even within the axonal compartment there is a mechanism driving the ‘hyper-
localization' of transcripts (Zivraj et al., 2010).  
 The use of high throughput RNA sequencing has led to a more comprehensive 
characterization of the axonal transcriptome during development (Bigler et al., 2017; Minis et al., 
2014) and in disease (Baleriola et al., 2014). Sequencing of peripheral axons from rat embryonic rat 
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DRGs revealed about 6118 localized mRNAs, which included about 80% of prior identified 
transcripts in Gumy et al. (2011), the highest number to date (Minis et al., 2014). This rich dataset 
provided opportunities for computational analysis to discover rules governing mRNA localization in 
axons. The authors did not focus their search on 3’UTRs, sites that are known to contain such 
regulatory elements. They found motifs that can be equally found in any region an mRNA and that 
are unknown to be associated with any RNA-binding protein (RBP). Therefore, their relevance is 
unclear. Finally, by increasing the depth of sequencing Taliaferro and colleagues discovered that 
distal alternative last exons drive localization of gene isoforms to neurites (Taliaferro et al., 2016).  
 
1.3 RBPs: regulators of RNA localization and translation 
As discussed in the prior sections, there is extensive evidence that axonal mRNA localization 
and translation occurs and, that it plays an important role in nervous system development and 
disease (Batista and Hengst, 2016; Jung et al., 2012, 2014). One key observation is that both axonal 
mRNA localization and translation are highly regulated developmentally as well as in response to 
extrinsic cues. This poses an interesting question, how are axonal mRNA localization and translation 
specified? This is believed to be mediated by RNA-binding proteins (RBPs). By interacting with 
select mRNAs through binding to specific regulatory motifs, RBPs form messenger 
ribonucleoprotein complexes (mRNPs) that are then transported to their subcellular location by 
motor proteins (Kiebler and Bassell, 2006). Moreover, mRNAs are translationally silent during this 
transport process, thus providing a dual means of regulation (Besse and Ephrussi, 2008). In the 
following section, I will briefly discuss the role of RBPs in regulating axonal mRNA localization and 
its functional consequences. Then, I will review the PUF family of RBPs in the context of mRNA 
localization and translation regulation, as members of this family are the focus of the work presented 
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in this thesis. Finally, I will discuss the computational and molecular tools that have allowed for the 
identification of regulatory sequence elements (motifs) and their association with RBPs.  
 
1.3.1 Neuronal mRNPs 
The life of cellular mRNAs is dictated by their interactions with RBPs. In fact, it has been 
hypothesized that the fate of a mRNA is sealed as soon as it is transcribed. (Haimovich et al., 2013). 
To understand how mRNA localization and the translation is regulated in neurons, researchers have 
tried to decode the mechanism by which RBPs interact with select mRNAs to form mRNPs. The 
complexity of this code can be astounding, as a single RBP can interact with hundreds of mRNAs 
(Ascano et al., 2012; Patel et al., 2012), and conversely, a single mRNA can associate with several 
RBPs. For example, β-Actin  is known to bind to at least 10 RBPs, many of which regulate its 
subcellular localization and or translation (Glinka et al., 2010; Klein et al., 2013; Ma et al., 2011; Ross 
et al., 1997; Todd et al., 2010). Interestingly, unlike previously thought, many mRNAs are present at 
low or single copy numbers in RNA granules (Amrute-Nayak and Bullock, 2012; Buxbaum et al., 
2014; Mikl et al., 2011). Moreover, the composition of RNA granules is more heterogeneous than 
initially expected (Fritzsche et al., 2013).  
Subcellular transport of mRNPs is mediated by molecular motor proteins and not stochastic 
diffusion. This form of active transport in neurites exhibits long, processive, and oscillatory 
movement (Park et al., 2014; Tübing et al., 2010). Interestingly, local axonal translation can modulate 
transport in response to environmental cues by regulating the translation of motor protein cofactors 
(Villarin et al., 2016). The composition and subcellular localization of mRNPs are in turn controlled 
by a unique combination of cis-acting sequence elements (Jambhekar and Derisi, 2007; Shahbabian 
and Chartrand, 2012). RBPs have been hypothesized to serve as adapters that associate mRNPs with 
microtubule based motors and (Davidovic et al., 2007). There is substantial evidence suggesting that 
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the association of a mRNA with an RBP is required for efficient subcellular transport and, is 
mediated by localization sequence elements in the mRNA. For example, the number of localization 
elements on a mRNA has been found to correlate with the number of associated motor proteins 
(Sladewski et al., 2013). Increasing the number of localization elements also improves the efficiency 
of mRNP transport (Amrute-Nayak and Bullock, 2012). Finally, altering an RBP copy numbers or 
its RNA binding function can lead to defects in mRNP localization (Alami et al., 2014).  
 
1.3.2 PUF family 
The PUF (Pumilio and FBF) family of RNA-binding proteins regulates mRNA expression 
and localization of target mRNAs (Quenault et al., 2011). Members of this family share a highly 
evolutionarily conserved homology RNA-binding domain (RBD) (Wickens et al., 2002; Zamore et 
al., 1997; Zhang et al., 1997). This RBD is structurally and genetically modular, consisting of several 
of several repeats each of which recognizes a specific nucleotide base (Edwards, 2015; Edwards et 
al., 2001; Wang et al., 2001, 2002). This has allowed for the evolution of mRNA target specificity 
and recognition. Two Pumilio homologs (PUM1 and PUM2), sharing up to 94% of the PUM-HD, 
have been identified in mammals  (Spassov and Jurecic, 2002). The mammalian consensus binding 
element often termed the Pumilio response element (PRE) consists of an octameric nucleotide 
sequence described initially as UGUANAUA (Galgano et al., 2008; Hafner et al., 2010; Morris et al., 
2008). 
In yeast, several PUFs members are responsible for regulating the localization and 
translation of more than 10% of the transcriptome (Gerber et al., 2004; Haramati et al., 2017). Here, 
specific PUFs associate with mRNAs encoding for components of distinct organelles. For example, 
Puf3 is associated with mRNAs encoding mitochondrial components  (Gerber et al., 2004; Saint-
Georges et al., 2008), while Puf4 and Puf5 are often associated with mRNAs encoding nuclear 
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components (Gerber et al., 2004), and Puf1 and Puf2 with mRNAs encoding membrane-associated 
proteins (Gerber et al., 2004; Porter et al., 2015). The function of these proteins is illustrated by the 
well-studied regulation of Ash1 mRNA asymmetric localization and translation in yeast. Here, Puf6 
associates with Ash1 mRNA post-transcriptionally and represses its translation while promoting its 
localization to the distal bud tip (Deng et al., 2008; Gu et al., 2004). Interestingly, the shared RNA 
binding preferences among PUFs has resulted in the emergence of an RNA regulatory “super-
network” whose behavior can be modulated by the stoichiometry of its members. Our 
understanding of the diverse roles that these RBPs perform in yeast continues to evolve as novel 
functions emerge (Haramati et al., 2017). 
In Drosophila, together with the RBPs partners Nanos and Brain Tumor, Pumilio is 
responsible for regulating mRNA localization, stability, and translation with functional consequences 
for embryonic development, stem cell maintenance and differentiation, fertility and neurologic 
processes (Arvola et al., 2017). During anterior-posterior patterning, Pumilio acts together with 
Nanos (Nos) to repress the localization and translation of hunchback mRNA at the posterior pole to 
control embryonic development (Nüsslein-Volhard and Lehmann, 1987; Sonoda and Wharton, 
1999; Wharton et al., 1998; Wreden et al., 1997). Pumilio is required for proper Drosophila germline 
development by regulating germline stem cell self-renewal and asymmetric division (Asaoka-Taguchi 
et al., 1999; Joly et al., 2013; Lin and Spradling, 1997). A screen for transcriptionally regulated genes 
during memory formation identified Pumilio as a regulator of long-term memory (Dubnau et al., 
2003). Moreover, further analysis of Pumilio target mRNAs revealed an enrichment for genes that 
are synaptically localized and potentially locally translated (Chen et al., 2008). Finally, Pumilio 
regulates dendritic and synaptic morphogenesis as well as neuron excitability in Drosophila (Bhogal 
et al., 2016; Mee et al., 2004; Menon et al., 2004; Schweers et al., 2002; Ye et al., 2004).  
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 Similarly, PUMs have also been implicated in the regulation of nervous system development 
and reproduction in mammalians. Pumilio-2 and Staufen-2 RNA granules are apically localized in 
progenitor cortical radial glial cells promoting self-renewal and preventing premature neuronal 
differentiation (Vessey et al., 2012). A more recent study demonstrated that both Pum1 and Pum2 
are critical for hippocampal neurogenesis and function (Zhang et al., 2017). Additionally, Pum2 has 
been shown to form dendritically localized ribonucleoprotein particles and stress granules where it is 
involved in regulating the proper formation of dendritic spines and synaptic plasticity  (Siemen et al., 
2011; Vessey et al., 2006, 2010). Pum1 knockout mice develop motor dysfunction through 
neurodegenerative processes in the cerebellum caused by Ataxin-1 overexpression (Gennarino et al., 
2015). 
  Mechanistically, PUMs are thought to inhibit translation and mRNA stability by recruiting 
specific factors to target mRNAs. Specifically, Pumilio can regulate mRNA deadenylation by the 
recruitment of CPEB or the CCR4-Pop2-NOT complex in a context specific and combinatorial 
manner that is not entirely understood (Campbell et al., 2012; Piqué et al., 2008; Van Etten et al., 
2012; Weidmann et al., 2014). Pumilio proteins have been predicted to interact with miRNAs; 
specifically, Pum1 has been shown to repress translation of p27-mRNA through the recruitment of 









Chapter 2. Thesis Outline and Contributions 
In the prior chapter I reviewed the evidence for localized translation and how is mainly 
determined by RBP regulated mRNA localization. An outstanding question that I decided to address 
is: how is the identity of axonally localized mRNAs globally determined in early developing neurons? 
Thus, I test the hypothesis that RBPs act as molecular filters in regulating the composition of 
asymmetrically localized mRNAs in axons of developing neurons. My findings challenge the 
prevailing notion that active mRNA transport is the main mode of regulation by identifying an 
exclusion mechanism by which mRNAs containing a specific motif are retained in the cell body. I 
also discover a new role for Pum2 by identifying it as the main effector in this regulatory process. In 
the following chapter, I describe the materials and methods used in these studies. In Chapter 4, I 
present the computational work to identify motifs that are informative of axonal mRNA localization 
and translation as well as the verification of the strongest motif in regulating this processes in-vitro. 
In Chapter 5, I demonstrate that this motif is strongly associated with Pum2 and test whether Pum2 
regulates axonal mRNA localization and translation of endogenous mRNAs containing the motif. In 
Chapter 6, I test the functional consequences of disrupting this regulatory mechanism by 
characterizing the developmental phenotypes of developing cortical neurons in-vivo as well as 
regenerating axons in-vitro. Finally, in Chapter 7 I synthesize these findings in context and present 
ideas for further testing.  The work presented in the main text of my thesis was mostly carried out by 
myself with one main exception. The in-vivo work was carried out in collaboration with Dan Iascone, 
a graduate student member of Dr. Franck Polleux’s laboratory at Columbia University.  Additionally, 
I received some assistance from a rotation student, Helena Pernice, in the axonal injury work. 
Moreover, a current member of the lab, Lisa Randolph, helped test and verify some qPCR targets 
from the RNA sequencing results. In addition to the work presented in the main text, I collaborated 
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with other lab members resulting in two publications which are included in the Appendix and that I 
describe below (Batista et al., 2017; Villarin et al., 2016). 
The work by Villarin et al. (2016) demonstrated that axons can modify the dynamics and 
cargo of retrograde transport in response to acute changing demands by locally synthesizing dynein 
cofactors. An interesting observation was that Lis1 mRNA was recruited to axons upon NGF 
deprivation and stimulation. Coincidentally, it had been recently demonstrated that APC functions 
as an RBP that transports mRNAs into axons and that Lis1 was among the targets (Preitner et al., 
2014). Given my interest in the regulation of axon mRNA localization by RBPs, I decided to apply 
bioinformatics analysis in order to identify the binding site of APC to Lis1 mRNA. By applying 
CIMS (Moore et al., 2014) and PIPE-CLIP (Chen et al., 2014) analysis to the HITS-CLIP data 
generated by Preitner et al. (2014) I identified the binding region of APC which also contained the 
reported CUGU motif that was reported for APC. Additional work by Villarin et al. (2016) 
demonstrated the functional relevance of this binding site since blocking it with an LNA disrupted 
the localization and translation of Lis1 mRNA in axons. Finally, I used FISH to test whether other 
dynein cofactors, namely Nde1 and Ndel1, are also co-recruited to axons in response to acute 
demands. I found them to be enriched in axons in response to NGF withdrawal but not NGF 
stimulation suggesting that together with Lis1 they might be part of an RNP complex that is co-
regulated. My contributions in this publication are presented in Figure7A and Supplementary Figure 
2. 
 Batista et al. (2017) asked whether axonal translation was required for pre-synapse 
formation. Using PDL-coated beads as a way to induce pre-synapses we showed that axonal 
synthesis of SNAP25 was indeed required to form functional pre-synapses capable of vesicle release. 
I was specifically interested in the recruitment and translation of SNAP25 mRNA in axons. Using 
FISH, I found SNAP25 mRNA to be recruited to the site of synapse formation upon simulation 
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with PDL-coated beads. One technically challenging question due to the low biochemical yields of 
axonal preparations was whether SNAP25 protein accumulated in axons over time during synapse 
formation. To address this, I modified and built a microfluidic device that allowed for greater 
quantities of protein to be extracted from axons based on a prior design (Park et al., 2009). Using 
this new device, I found an accumulation of SNAP25 in axons during pre-synapse formation that 
was blocked with local application of protein synthesis inhibitors. Finally, I also validated 
demonstrated that puromycilation labeling as a readout for translation correlates well with the 
localization of active markers of translation (p-4EBP1). My contribution to this paper are shown in 

















Chapter 3. Materials and Methods 
3.1. Animal Use and Cell Culture 
3.1.1. Rat Handling 
Pregnant Sprague-Dawley rats (Rattus norvegicus) were obtained from Envigo (Indianapolis, 
IN) and housed for 2 days at the barrier facility at the Columbia University Institute of Comparative 
Medicine. All rodent procedures were approved by the Columbia University Institutional Animal 
Care and Use Committee. 
 
3.1.2. Euthanasia 
Rats were euthanized by gas displacement with 5% min-1 CO2 until there were no signs of 
breathing, approximately 6-7 min. A secondary physical means of euthanasia, bilateral thoracotomy, 
was performed to ensure death. 
 
3.1.3. Microfluidic Devices 
Bipartite microfluidic devices with a set of 750 µm-long microgroove barriers were designed 
in house and produced according to established protocol (Park et al., 2006; Taylor et al., 2005). 
Microfluidic chambers were produced from silicon masters using PDMS (Sylgard 184, or Qsil 216) 
by combining an elastomer base with curing agent in a 9:1 ratio and mixed thoroughly for 5 mins. 
Trapped gases were removed by placing the mixture in a vacuum desiccator for 1 h. PDMS molds 
were baked for at 4 h at 65°C. Individual devices were cut and reservoir holes were punched. 




3.1.4. Culture Materials 
For Puro-PLA experiments glass bottom dishes (MatTek, Ashland, MA) were coated with 
0.01 mg/mL PLL (Trevigen, Gaithersburg, MD) for 1 h at 37°C and then rinsed with water three 
times and allowed to air-dry. For the rest of the experiments glass coverslips (25 mm; Carolina 
Biological Supply Company, Burlington, NC) were rinsed with water twice and then coated with 
PLL in a 6-well Nunc cell-culture treated 6-well plate for 1 h at 37°C. Coverslips were then rinsed 
with water three times and allowed to air-dry. 
 
3.1.5. DRG Neuron Culture 
DRGs were harvested from E15 rat embryos and trypsinized by incubating with TrypLE 
Express for 30 min in a water bath at 37°C. DRGs were centrifuged to remove TrypLE solution. 
They were washed once with DRG growth medium (Neurobasal, 1x B27, 2 mM glutamate, 20 µM 
5-FdU, 50 ng/mL NGF) and resuspended in the same media and dissociated with a fine pipette tip.  
About 40,000 cells were seeded per chamber and allowed to attach for 30 mins before more medium 
was added.  
 
3.2. Experimental Treatments 
3.2.1. Lentivirus Preparation 
Lentivirus expression plasmids with shRNAs targeting Pum2 or control sequence were 
obtained from transOMIC (Huntsville, AL). These plasmids were slightly altered by replacing the 
original mCMV promoter with the hUbc for better expression in primary neurons. Also, the 
reporter ZsGreen1 gene and Puromycin resistance cassette were replaced by eGFP. The hairpins in 
these plasmids are designed using algorithms and technology that enhances specificity and potency 
(Auyeung et al., 2013; Knott et al., 2014). Lentiviruses are produced by transfecting HEK293T cells 
22
with the lentiviral plasmid and packaging plasmids (pCMVΔ R8.9 and pHCMV VSVg) using 
Calfectin (Signagen, Rockville, MD). Medium is changed to DRG growth medium without NGF or 
FdU after 8h. Viruses are collected 24h later, aliquoted and stored at -80°C. The titers for every 
batch are calculated using a qPCR based kit from Applied Biological Materials (Richmond, Canada) 
according to the manufacturer’s instructions.  
 
3.2.2. Neuronal Transduction 
Primary DRG neurons were infected 30 mins after plating at an MOI of 40 to obtain more 






Figure 3.1: shRNA lentiviruses are highly effective. Pum1 or Pum2 shRNA 
lentiviruses were added to primary DRG neurons after plating in microfluidic chambers. 
Protein lysates were obtained 96h after and used for western blotting. 
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3.2.3. In-utero Electroporation 
 In utero cortical electroporation was performed according to well established protocols 
(Courchet et al., 2013; Hand and Polleux, 2011). shRNA plasmids at a concentration of 1 µg/µL 
were injected into one lateral hemisphere of E15.5 embryos and driven into progenitor cortical 
neurons by electroporation. Four pulses of 45 V for 50 ms with 500 ms interval were used. Animals 
were sacrificed 5 days or 3 weeks after birth by perfusion with 4% paraformaldehyde (PFA, Electron 
Microscopy Sciences).  
 
3.3. Imaging based techniques 
3.3.1. Immunofluorescence 
Primary DRG neurons were fixed with 4% paraformaldehyde (PFA) in cytoskeletal 
preservation buffer (10 mM MES, 138 mM KCl, 3 mM MgCl2, 2 mM EGTA, 320 mM sucrose, pH 
6.1) for 15 minutes at room temperature. Samples were washed with PBS (3 times for 5 minutes 
each) and permeabilized in PBS with 0.3% Triton X-100 for 5 minutes. Cells were rinsed briefly in 
PBS and blocked for 1 h at room temperature with 5% BSA in PBS-T (0.1% Tween-20 in 1X PBS). 
Samples were incubated overnight in 1% BSA in PBS-T at 4°C with the following primary 
antibodies:  β-III-tubulin (1:1000, Biolegend), Pum1 (1:200, Bethyl), Pum2 (1:200, Bethyl).  Samples 
were washed with PBS-T (3 times, 5 minutes each) and incubated for 1 hour at room temperature 
with fluorophore-conjugated Alexa secondary antibodies (1:1000, Thermo Fisher Scientific). 
Samples were washed with PBS (3 times, 5 minutes each), and mounted with ProLong Diamond 
antifade reagent (Thermo Fisher Scientific). Imaging was carried out using an EC Plan- Neofluar 
40x/1.3 objective on an Axio-Observer.Z1 microscope equipped with an AxioCam MRm Rev. 3 
camera (Zeiss, Thornwood, NY). 
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3.3.2. Puromycilation 
 Primary DRG neurons grown in microfluidic devices were incubated with 2 μM puromycin 
only in the axonal compartment at 37°C for 10 minutes. Cells were washed once with fresh DRG 
growth medium and then fixed and processed as described above for immunocytochemistry with 
the following modifications. Samples were incubated overnight at 4°C with α-Puromycin (1:1000, 
Millipore Sigma) and the next day with fluorescence conjugated β-III-tubulin (1:500, BioLegend) and 
Alexa-conjugated secondary for 1 h at room temperature. 
 
3.3.3. Puro-PLA 
 Puro-PLA assay to detect newly synthesized proteins following a established protocol (tom 
Dieck et al., 2015). Briefly, the puromycilation procedure detailed above was combined with the 
Duolink (Sigma-Aldrich) assay according to the manufacturer’s instructions as follows. After 
primary antibody incubation and washes samples were incubated with Plus and Minus conjugated 
PLA probes for 1h at 37C in humidity chambers. Samples were then washed twice in TBS-T for 5 
minutes each time. Ligation of the probes was carried out for 30 mins at 37°C and followed with 2 
washes for 2 minutes with TBS-T. Amplification using the red reagent mix was performed for  
100 mins at 37°C. Samples were washed with TBS and incubated with fluorescence conjugated β-
III-tubulin (1:500, BioLegend ) in TBS for 1 h at room temperature. Finally, samples were rinsed in 
TBS and mounted using Duolink Mounting Media with DAPI. 
 
3.4. Biochemistry 
3.4.1. Quantitative Real Time PCR 
 Total RNA was extracted from either the somatic or axonal compartment using the Single 
Cell RNA Purification Kit (Norgen Biotech) from 6 to 12 microfluidic chambers. Samples were 
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treated with DNAseI. Quantitative PCR was performed with the One-Step RT-qPCR from RNA kit 
(Bio-Rad) according to manufacturer’s instructions using gene specific TaqMan probes. 10ng of 
somatic RNA was used per reaction. Axonal RNA was too low to measure therefore loading was 
normalized to volume and results were normalized to a reference gene.  
 
3.4.2. RNA-Sequencing 
 Total RNA was extracted from either the somatic or axonal compartment using the Single 
Cell RNA Purification Kit (Norgen Biotech) from 6 microfluidic chambers. Samples were submitted 
to GENEWIZ for RNA-Seq. mRNA was enriched by poly-A pulldown. Axonal RNA was subjected 
to SMART-Seq v4 Ultra Low Input RNA Kit while somatic RNA library was prepared using a 
standard mRNA kit. Generated libraries were pulled together and sequenced using a HiSeq 2x150bp 
PE configuration in a single high output lane.  
 
3.5. Computational Analysis 
3.5.1. RNA-Sequencing Analysis 
 Publically available datasets were accessed and downloaded from the NCBI GEO database 
web server. Reads were pseudoaligned to that appropriate species transcriptome (mouse or rat) using 
kallisto under default conditions to generate transcript specific counts (Bray et al., 2016). For 
differential gene expression analysis, transcript counts were imported in R using tximport (Soneson 
et al., 2015) and analysis was performed with DESeq2 (Love et al., 2014). Generally, a stringent 
threshold was set to filter lowly expressed genes from downstream analysis by excluding genes 
whose expression level were under the 75th quartile.  
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3.5.2. Motif Discovery and Testing 
 Motif discovery and analysis was performed using FIRE (Elemento et al., 2007) with a few 
modifications. Full length annotated 3’UTRs were downloaded from UCSC database using 
Usegalaxy webserver. Duplicates were removed and sequence homology files were prepared using 
scripts included in the FIRE suite. Data files containing either continuous or discrete information 
were prepared from the RNA-Seq analysis and provided to the program accordingly. Since the 
sequencing was not deep enough to accurately measure transcript isoform expression and 3’UTRs 
are generally under-annotated, the isoforms containing the longest 3’UTR were often used in the 
analysis when multiple isoforms exist. The number of bins were set to result in 200 genes per bin. 
For de novo motif discovery analysis minr was set at 1.  
 
3.5.3. Statistical Analysis 
Statistical analysis was performed using GraphPad Prism 6 software (GraphPad Software, 












Chapter 4. The Pumilio-Binding Element is informative of neuronal mRNA 
localization 
4.1. Rationale and Summary 
 To gain a more complete understanding of the full axonal transcriptome, several high-
throughput studies were conducted that measured axonal mRNA from neurons grown in 
compartmentalized chambers. These studies revealed a core cohort of mRNAs present in every 
axonal transcriptome as well as other mRNAs that were neuronal type and developmental stage 
specific. This prompted the search for the regulatory motifs and RBPs responsible for specificity in 
the sorting of mRNAs into the axonal compartment. It was hypothesized that a gatekeeping 
mechanism that acts by selectively restricting the localization of specific mRNAs into axons might 
exist, yet the identity of this mechanism has remained elusive.  
The idea that molecular “addresses”, termed “zipcodes”, in the form of sequence or 
structural motifs in the 3’UTR of mRNAs are required and sufficient for the asymmetric subcellular 
sorting of mRNAs is well established in biology. In the following studies, I conduct an extensive 
search for cis-acting elements in the 3’UTR of mRNAs, where most regulatory motifs reside, that are 
informative of axonal mRNA localization in developing neurons using the computational algorithm 
FIRE. I am able to identify the Pumilio-Binding Element (PBE) (5’-UGUAHANR-3’)  as a highly 
informative motif of axonal mRNA localization and translation. Moreover, I show that this motif is 
sufficient to restrict the axonal localization and translation of a transcript when present in the 
3’UTR. These findings suggest that the PBE might work as a gatekeeping signal to control early 
mRNA composition of developing axons.  
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4.2. Results 
4.2.1. The PBE is negatively associated with axonal mRNA localization in developing 
sensory neurons 
To identify motifs that are informative of axonal mRNA localization, I applied the 
computational algorithm FIRE on discovery mode to the dataset from Minis et al. (2014). 
Surprisingly, all of the identified motifs are over-represented in mRNAs that are somatically 
localized, and under-represented in axonally enriched mRNAs (FIGURE 4.1). This indicates that 
there might be an important mechanism for regulating axonal mRNA localization by exclusion. The 
most informative motif (UGUAUAU) contains the core element (UGUA) of the mRNA motif for 
the PUF family of RNA binding proteins and, closely follows the binding motif recognized by the 
mammalian homologues Pum1 and Pum2 (UGUAHAUA), here referred to as the Pumilio binding 
element (PBE). I used an orthogonal approach to identify motifs regulating axonal mRNA 
localization by applying the computational algorithm DRIMust (Leibovich et al., 2013) to the same 
dataset. Interestingly, this algorithm found no motifs when using axonally enriched mRNAs as target 
sequences, but found two motifs, one of which is similar to the previously one identified by FIRE 









Figure 4.1: Motif discovery with FIRE reveals pattern of somatic mRNA retention in 
neurons. FIRE was run on ‘discovery mode’ in a neuronal genome-wide subcellular 
localization measurement dataset (Minis et al. 2014). The top 10 motifs are shown. The 
following parameters were used, k=7, ebins=20, minr=1. Yellow intensity corresponds to the 
degree of enrichment of a motif while blue intensity refers to the degree of depletion of a 
motif. The left bins contain mRNAs that are relatively enriched in cell bodies, while the right 
bins contain mRNAs that are relatively enriched in axons. Each bin contains about 200 
mRNAs.  
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 Since both approaches identified a motif very close to the PBE and, this family of RBP is 
known to regulate mRNA localization, degradation, and translation, I decided to focus on this motif 
for further analysis. RNA immunoprecipitation and CLIP studies have demonstrated that both, 
Pum1 and Pum2 have an affinity for A,C, and U but not G at the fifth base the binding site.  To test 
the specificity of the motif I ran FIRE on non-discovery mode to measure the information content 
and significance of changing this fifth base. I found that each instance of the motif was still highly 
significant when the fifth base was either A,C, or U, but non-significant when it was G as it would 
be for a PBE (FIGURE 4.3). Although, Pum1 and Pum2 recognize the same core motif 
(UGUAHAUA), several studies of the RNA binding affinities these two proteins have revealed that 
Pum2 is much more flexible in its nucleotide recognition at the eights base with a consensus motif 
of UGUAHAUW (Zhang et al., 2017).  In the original de-novo motif discovery this base position 
was not addressed, I tested the contribution of this base to the mutual information content of the 
motif using FIRE and, found that the Pum2 motif is slightly more informative (FIGURE 4.4).  
 Altogether, this initial analysis revealed that an important mode of axonal mRNA 
localization control might be due to exclusion of specific classes of mRNAs. Moreover, it identified 
 
 
Figure 4.2: Motif discovery with DRIMust also identified the core of the PBE as 
significantly enriched in somatically retained mRNAs. 3’UTR sequences of the top 100 
somatically enriched mRNAs and the top 100 axonally enriched mRNAs were provided for 
comparison. Algorithm was run in the default mode allowing for motifs to be from 5 to 10 
nucleotides in size and the minimum statistical threshold was set at 10-6. 
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the PBE as a major motif contributing to this process by being highly over-represented in 
somatically localized mRNAs and highly under-represented in axonally enriched mRNAs. Finally, 
the Pum2 motif might be slightly more informative than its close relative Pum1 since it is more 







Figure 4.3: Testing the mutual information content by varying the fifth base of the motif 
demonstrated high specificity for the PBE. FIRE was run on ‘non-discovery mode’ in a 
neuronal genome-wide subcellular localization measurement dataset (Minis et al. 2014). The 
following motifs were tested: UGUA[ACU]AUA, UGUAAAUA, UGUAUAUA, 
UGUACAUA, UGUAGAUA. Only motifs found to be significant are shown. Yellow intensity 
corresponds to the degree of enrichment of a motif while blue intensity refers to the degree of 
depletion of a motif. The left bins contain mRNAs that are relatively enriched in cell bodies, 
while the right bins contain mRNAs that are relatively enriched in axons. Each bin contains 




4.2.2 The PBE is informative of neuronal mRNA localization across different neuronal cell 
types  
Since sensory neurons are morphologically distinct in that they are bipolar, having a central a 
peripheral axon but no dendrite, I decided to test whether the PBE is also informative of mRNA 
localization in more morphologically complex CNS neurons. Recently, Taliaferro et al. (2016) 
sequenced the somatic and neuritic compartments of developing cortical neurons as well as 
differentiated brain tumor derived N2A cells to uncover that alternative last exons confer isoform 
specific localization of mRNAs into neurites. I applied FIRE to their dataset to test whether the 
Pum1 and Pum2 binding motifs were informative of subcellular mRNA localization in these cells. I 
found that across all cell types both motifs were significant (FIGURE 4.5). Like in sensory neurons 
the motifs were over-represented in the somatically localized mRNAs and under-represented in the 
neurotically enriched mRNAs. Interestingly, the Pum2 motif was much more informative than the 
Pum1 motif across all cell types, and for primary cortical neurons the Pum1 motif was borderline 
 
 
Figure 4.4: Pum2 specific PBE variant is slightly more informative. FIRE was run on 
‘non-discovery mode’ in a neuronal genome-wide subcellular localization measurement dataset 
(Minis et al. 2014). Two variants of the PBE motifs were tested : UGUA[ACU]AU[AU] (Pum2 
preferred) and UGUA[ACU]AUA (Pum1 and Pum2). Yellow intensity corresponds to the 
degree of enrichment of a motif while blue intensity refers to the degree of depletion of a motif. 
The left bins contain mRNAs that are relatively enriched in cell bodies, while the right bins 




insignificant (Z<10).  This data suggests that there is an exclusion mechanism by which mRNAs 
containing a PBE are restricted from being localized in neurites of developing neurons.  
 
 
4.2.3. The PBE is associated with mRNAs that are translated in adult axons  
Two interesting questions arise from these in-vitro findings: How relevant is this exclusion 
mechanism in-vivo and, is it developmentally regulated? To answer these questions, I tested the 




Figure 4.5: The PBE is associated with somatically enriched mRNAs across different cell 
types. FIRE was run on ‘non-discovery mode’ in primary cortical neuron genome-wide 
subcellular localization measurement dataset (TOP) and Neuro2A neuroblastoma derived cell line 
(BOTTOM) (Taliaferro et al. 2015). The two variants of the PBE were tested, 
UGUA[ACU]AU[AU] (Pum2 preferred) and UGUA[ACU]AUA (Pum1 and Pum2). Yellow 
intensity corresponds to the degree of enrichment of a motif while blue intensity refers to the 
degree of depletion of a motif. The left bins contain mRNAs that are relatively enriched in cell 
bodies, while the right bins contain mRNAs that are relatively enriched in neurites. Each bin 
contains about 200 mRNAs. 
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developing mouse retinal axon in-vivo across different developmental stages generated by Shigeoka 
et al. (2016). Although this dataset is enriched in translating mRNAs there is evidence suggesting 
that the local translatome and transcriptome are highly correlated (Gáspár and Ephrussi, 2017b; 
Zappulo et al., 2017b), moreover the Pumilio family of RNA binding protein are known to regulate 
both mRNA localization and translation in yeast (Quenault et al., 2011). When focusing the analysis 
on the mRNAs translated in axons at different developmental stages (E17.5, P0.5, P7.5, and Adult) I 
found the Pum2 motif to be highly informative of temporal axonal mRNA translation, specifically 
by being highly under-represented in mRNAs that are translated early (P0.5) and over-represented in 
mRNAs that are translated late (P7.5 and Adult) (FIGURE 4.6.A).  
Since the strongest effects were observed at P0.5 and Adult and decided to focus on this 
stages for more detailed analysis. I performed FIRE analysis on the measured fold changes in the 
translatome between these two stages which supported the prior finding that mRNAs containing the 
Pum2 motif are translated in adult axons but not in early development and, revealed the strength of 
this effect across different groups of mRNAs (FIGURE 4.6.B). Interestingly, this finding fits well 
with an observation described in a later chapter which shows that Pum2 protein is expression in the 
nervous system is high during early development and declines at later stages (FIGURE 5.2). Both of 
these observations together suggest that high expression of Pum2 in early developing neuron 
contribute to restrictive localization and translation of mRNAs containing the PBE in axons.  
35
  
4.2.4. The PBE is sufficient to decrease axonal mRNA localization and translation 
Based on all the computational findings I hypothesized that the PBE is restrictive of mRNA 
localization and translation in axons of developing neurons. To test this hypothesis I created a 
reporter system to measure the contribution of the PBE to the localization and translation of an 
mRNA in axons. I did this by adding the Actb 3’UTR, a well known axonal targeting 3’UTR, to a 
Gfp expression construct, and then to this I added either two PBE (UGUAUAUA) at the beginning 
and end of the 3’UTR, or a mutated version of the PBE (UGUAGAUA) were the fifth base is the 




Figure 4.6: PBE containing mRNAs are translated in adult axons. (A) FIRE was run on 
‘non-discovery mode’ on a dataset with discrete groups of mRNAs translated in mouse axons at 
different developmental stages (Shigeoka et al. 2016). (B) FIRE was run on ‘non-discovery mode’ 
on a quantification of axonal mRNA translation between P0.5 and Adult stages. The left bins 
contain mRNAs that are translated at P0.5, while the right bins contain mRNAs that are 
translated in adult. Each bin contains about 200 mRNAs. Yellow intensity corresponds to the 




PBE was sufficient to reduce the localization of this transcript while the mutated PBE version did 
not (FIGURE 4.7). To assess the localized translation of this reporters in axons, I applied the Puro-
PLA as described in Methods and by (tom Dieck et al., 2015). Similarly, I found that the presence of 
the PBE decreased the translation of Gfp in axons while the mutated version of the PBE did not 




Figure 4.7: The PBE is sufficient to restrict axonal localization of a reporter mRNA. 
Primary sensory neurons grown in microfluidic devices were infected with lentiviruses containing 
a Gfp reporter construct with the β-Actin 3’UTR with or without the PBE. Gfp mRNA 
expression levels was measured in axons using qPCR and normalized to the condition without 




Figure 4.8: The PBE decreases axonal protein synthesis of reporter mRNA. Schematic of 
Puro-PLA technique principal to detect newly synthesized proteins (TOP). Primary sensory 
neurons grown in microfluidic devices were infected with lentiviruses containing a Gfp reporter 
construct with the β-Actin 3’UTR with or without the PBE. Axonal Gfp mRNA translation for 
10 minutes was measured by using a Puro-PLA protocol (described in details in methods) (n=3 
biological replicates). ** p < 0.01, *** p < 0.001.  
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To verify that this motif indeed binds to Pum2 I co-expressed Pum2 and each of the 
reporter constructs in HEK293T cells and carried and RIP with qPCR. I found that Pum2 was able 
to pulldown the PBE containing construct with much higher affinity (FIGURE 4.9). Altogether, 
these findings support the hypothesis that the PBE, possibly due to Pum2 regulation, is sufficient to 







Figure 4.9: Pum2 protein associates with reporter mRNA containing the PBE. HEK293t 
cells were co-transfected with Pum2 and reporter mRNA with or without the PBE. Pum2 was 
immunoprecipitated and pulled-down reporter mRNA was measured using qPCR (n=3 biological 
replicates. ** p < 0.01. 
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 4.3. Interpretation 
In the search for “zipcodes” that regulate axonal mRNA localization, I expected to find a 
positive link between the presence of these “zipcodes” and the localization of an mRNA to axons in 
accordance to the prevailing view that RNA localization is actively regulated in this manner by RNA 
binding proteins (Eliscovich and Singer, 2017; Eliscovich et al., 2013). The finding that all of the 
neuronal mRNA localization motifs discovered are negatively associated with axonal mRNA 
localization was unexpected. This suggests that a major mechanism regulating axonal mRNA sorting 
is through the exclusion of mRNAs containing specific motifs.  Such a gating mechanism has several 
advantages and important implications for our understanding of mRNA localization in the 
developing neurons. First, it provides a molecular selectivity filter at an early time point where 
neuronal polarity and other physical barriers, such as the axon initial segment, are still actively 
developing. Secondly, it greatly increases the specificity for the cohort of mRNAs that are localized 
to axons by adding an extra criterion for their inclusion. Altogether, this mechanism provides a 
much safer system for the localization and translation of specific mRNAs in developing axons where 
resources, including the translational machinery, are limited, and where small errors could have a 
catastrophic impact on the system as a whole.  
Although several motifs were initially identified, the PBE was chosen for further analysis not 
only because it was the most informative, but because it is associated with the well-known PUF 
family of RNA binding proteins. The initial computational analysis strengthened this finding by 
demonstrating a high specificity in the nucleotide composition of the motif for the base affinities of 
Pum2, which was later demonstrated to bind to a reporter containing this motif. Interestingly, the 
PBE was also highly informative of neurite mRNA localization across other cell types suggesting 
that it might be universal during nervous system development. Looking at the axonal translatome 
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across different developmental stages revealed that PBE containing mRNAs are translated in mature 
and adult axons but not early developing axons. This supports the view that axonal mRNA 
localization and translation is dynamic and spatiotemporally regulated, and supports a role for the 
PBE in restricting axonal mRNA localization and translation in early development. Finally, the 
introduction of the PBE in an otherwise axonal localizing 3’UTR was sufficient to significantly 
reduce the localization and translation of an mRNA. 
There has been other attempts to identify localization motifs using genome-wide datasets 
mainly from the authors that generated them (Minis et al., 2014; Shigeoka et al., 2016b; Taliaferro et 
al., 2016; Zappulo et al., 2017b).  These analyses ultimately did not result in the discovery or 
characterization of novel localization elements or their trans-acting partners. There are several 
reasons for this shortcoming. One, they did not narrow the motif search to 3’UTR regions. While 
regulatory elements can also be found in the 5’UTR and even the CDS, the majority are 
predominantly present in the 3’UTR. Including all these regions in a single analysis increases the 
background noise and does not take advantage of the distinct evolutionary and regulatory pressure 
to which they are subject. Second, they did not use algorithms that incorporate genome-wide 
measurements in the analysis. Rather, they relied on algorithms that search for motif enrichment in 
selected sequences compared to background sequences. While this approach is widely successful for 
the identification of regulatory elements associated with discrete processes, such as binding 
preferences for RBPs or transcription factors, it lacks sensitivity for the identification of regulatory 
elements involved in biological processes that fall in a continuous spectrum, such as mRNA stability 
and localization.  
For these reasons, I decided to use a distinct computational approach that incorporated the 
information from the genome-wide mRNA localization measurements to identify motifs that are 
informative of axonal mRNA localization. I found such approach in FIRE which relies on the 
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concept of mutual information to measure the relationship between gene expression and the 
presence or absence of regulatory motifs without making assumptions about the underlying 
relationships or structure of the data (Elemento et al., 2007). One great advantage of this approach is 
that it increases sensitivity and reduces the likelihood of false positives. The success of this approach 
is evident by the findings described above. Yet, there are some limitations that if addressed will 
further expand the potential for new discoveries. FIRE, utilizes a motif optimization step by which a 
motif seed is gradually changed until it reaches a motif with the highest possible information 
content. This generally results in motifs that are more similar to predicted binding elements derived 
from biological experiments while eliminating redundant intermediate motifs (Elemento et al., 2007). 
Unfortunately, there might be instances where the motif optimization process might lead to the loss 
of an otherwise distinct and biologically significant motif than the final product. Additionally, there 
might be cases where the optimized motif while being the most computationally informative it 
might not represent an element found in biology. A parameter in the program can be modified to 
alter the threshold by which a seed motif and a similar but distinct motif should be optimized into 
one (minr). Making this parameter very stringent leads to identification of few and highly optimized 
motifs, while the opposite increases the overall number of motifs. Therefore, in order to maximize 
sensitivity and discovery a first approach should be to apply this program with no motif 
optimization (minr=0). Additionally, to increase the likelihood of identifying biologically relevant 
motifs the program should be run in parallel on non-discovery mode to test the information content 
of already known RBP and miRNA motifs. Altogether, the combination of these two approaches 





Chapter 5. Pum2 negatively regulates axonal mRNA localization and 
translation 
5.1. Rationale and Summary 
The PUF (Pumilio and FBF) family of RNA-binding proteins regulates mRNA expression 
and localization of specific target mRNAs containing the highly conserved PBE. The two 
mammalian homologues, Pum1 and Pum2, have been studied in the context of translational 
repressors with important roles in diverse processes. Their role in mRNA localization has been less 
studied, but there is some evidence that at least Pum2 is involved in RNA granule formation and 
perhaps indirectly on mRNA localization. In progenitor cortical radial glial cells, Pum2 granules are 
apically localized to restrict the localization and expression of specific mRNAs which is required for 
self-renewal and to prevent premature neuronal differentiation. Additionally, Pum2 has been shown 
to form dendritically localized ribonucleoprotein particles and stress granules that are involved in 
regulating proper formation of dendritic spines and synaptic plasticity. 
 In the following studies, I decided to better characterize the subcellular as well the 
developmental expression of Pum1 and Pum2 in nerve cells. I then studied the role of Pum2 in 
axonal mRNA localization and translation. Finally, I established that Pum2 is responsible for 
restricting the localization and translation of PBE containing mRNAs in the somatic compartment 
of developing neurons.  
 
5.2. Results 
5.2.1. Pum1/2 are differentially expressed 
Since Pum1 and Pum2 share a similar homology RNA binding domain and potentially 
recognize similar targets I decided to better characterize their subcellular localization in neurons as 
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well as their temporal expression in the mammalian brain. I found a striking difference between 
these two homologues. First, Pum2 is strictly localized to the somatic compartment of early 
developing embryonic primary neurons, while Pum1 is enriched in neurites and more specifically in 
axons (FIGURE 5.1). 
 Looking at different stages of mouse cortical development, I found that Pum2 protein 
expression peaked during the embryonic stage and progressively declined during development, while 
Pum1 expression briefly peaked postnatally before declining (FIGURE 5.2). This data is consistent 
with a recent finding by Zhang et al. (2017) that Pum1/2 are highly expressed during neurogenesis 
where they have a regulatory role.  The subcellular expression of Pum2 and its developemental 
expression decline is consistent with my prior finding that PBE containing mRNAs are somatically 
localized and that their translation in axons occurs at the adult stage when Pum2 levels are down. 
Therefore, further experiments in this chapter aim at characterizing the function of Pum2 in 







Figure 5.1: Pum1/2 are distincty localized in neurons. DIV2 primary sensory (TOP) or 
cortical neurons (BOTTOM) were immunostained with α-Pum1 (green) or α-Pum2 (green) 




5.2.2. RNA-Seq of Sensory Neurons in microfluidic devices resembles prior transcriptomes 
  To completely determine the regulatory role of Pum2 in neuronal mRNA localization, I 
measured the somatic and axonal transcriptomes of developing embryonic rat DRG neurons 
cultured in microfluidic chambers. By comparing the top expressed genes in my newly generated 
axonal transcriptome to the previously published mouse axonal transcriptome (Minis et al., 2014) 
and found that over 70% of my transcriptome overlapped. Gene Ontology analysis was distinct 
between axonal and somatically enriched transcripts with developmental programs being more 
prominent in the cell bodies and translation and mitochondrial processes in axons. Interestingly, 
somatically enriched categories coincide with enriched categories in PBE containing mRNAs (see 




Figure 5.2: Pum1/2 expression peaks at different times during cortical development. 
Mouse brain cortical lysates from different developmental stages were immuniblotted for 








Figure 5.3: RNA-Seq of rat sensory neurons revealed similar class of mRNAs enriched in 
axons as previously identified. Venn diagram representing the overlap between the third 
quartile of mRNAs measured in axons from rat sensory neurons (this work) and mouse sensory 
neurons (Minis et al. 2014) (TOP). Gene ontology enrichment analysis results from DAVID on 
the set of mRNAs enriched in either cell bodies or axons as identified by the transcriptome 
(BOTTOM).    
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I wanted to test whether the PBE is informative of neuronal mRNA localization under 
control conditions in this newly obtained transcriptome and, whether it follows the same pattern 
that I previously observed in other transcriptomes. I used FIRE in non-discovery mode and found 
that indeed the Pum2 motif was informative of neuronal mRNA localization, more specifically it 
was over-represented in somatically localized mRNAs and under-represented in axonal mRNAs as 
previously observed in other transcriptomes (FIGURE 5.4). Thus, this finding underscores the 
importance of the PBE motif as a regulator of neuronal mRNA localization and validates our model 









Figure 5.4: The PBE is also restrictive of mRNA localization in the newly produced 
subcellular transcriptome of sensory neurons. FIRE was run on ‘non-discovery mode’ to 
test the information content of the PBE on the genome wide subcellular mRNA measurements 
obtained from sequencing rat sensory neurons growing in microfluidic devices. Yellow intensity 
corresponds to the degree of enrichment of a motif while blue intensity refers to the degree of 
depletion of a motif. The left bins contain mRNAs that are relatively enriched in cell bodies, 
while the right bins contain mRNAs that are relatively enriched in axons. Each bin contains 
about 200 mRNAs.   
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5.2.3. Pum2 selectively changes axonal transcriptome composition without altering overall 
neuronal mRNA levels.  
Since it has been reported that Pum1/2 can regulate mRNA stability I first wanted to check 
whether knocking down Pum2 would result in major changes of the whole neuronal transcriptome. 
Using differential gene expression analysis on the somatic transcriptomes, I found that knocking 
down Pum2 did not result in any significant changes in overall mRNA expression (FIGURE 5.6). 
The data also shows that the hairpin shRNA was highly specific for Pum2 (FIGURE 5.6). On the 
contrary, when I applied differential gene expression analysis to the axonal transcriptomes, I found 
that Pum2 knockdown resulted in a great number of differentially expressed genes (FIGURE 5.7). 
Altogether, these findings suggest that Pum2 regulates axonal mRNA content without regulating 










Figure 5.5: Knock down of Pum2 did not cause major changes in the whole neuronal 
transcriptome. DIV7 sensory rat neurons grown in microfluidic chambers and treated with 
either shControl or shPumilio2 were subjected to RNA-Seq. MA Plot from DESeq2 differential 
expression analysis in neuronal cell bodies between the two conditions (TOP). Table showing 




Figure 5.6: Knock down of Pum2 resulted in major changes to the axonal transcriptome. 
DIV7 sensory rat neurons grown in microfluidic chambers and treated with either shControl or 
shPumilio2 were subjected to RNA-Seq. MA Plot from DESeq2 differential expression analysis 
in axons between the two conditions (TOP). Table showing the top 10 increased or decreased 
genes and whether they contain a PBE.  
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5.2.4. mRNA localization of PBE containing mRNAs in axons is increased by Pum2 
knockdown.  
Next, I tested the specificity of the axonal transcriptome changes upon Pum2 knockdown. 
Specifically, I analyzed the mutual information content of the PBE across axonal mRNA expression 
of shControl vs shPum2. I found that the PBE was highly under-represented in a group of mRNAs 
whose expression did not change across conditions, while it was over-represented in mRNAs that 
were enriched in axons after the knockdown (FIGURE 5.7A). I also tested this effect by directly 
comparing the group of mRNAs that were upregulated in axons after Pum2 knockdown to the 
group of mRNAs that were unchanged using FIRE in binary mode. Similarly, I observed a strong 
over-representation of the PBE in the set of mRNAs that were localized to axon upon knockdown 
(FIGURE 5.7B).  
I found that the PBE is still highly informative of neuronal mRNA localization when using 
embryonic DRG neurons grown in microfluidic chambers, thus supporting the use of this system 
for current and future work on this topic, as well as supporting the main hypothesis that the PBE 
restricts mRNAs from localizing in axons of developing neurons. Moreover, knocking down Pum2 
did not have any effects in overall neuronal mRNA stability while it resulted in a major remodeling 
of the axonal translatome. Specifically, Pum2 knockdown resulted in an increase of PBE containing 








5.2.5. Pum2 increases overall translation levels in axons as well as translation of a specific 
target mRNA. 
 Since Pum2 downregulations leads to an increase of PBE containing mRNAs in axons I 
hypothesize that overall axonal translation might be affected due to their presence. I measured 
axonal translation capacity under naïve conditions in sensory neuron axons by measuring the 
 
 
Figure 5.7: The PBE is enriched in mRNAs upregulated in axons upon Pum2 knock 
down. (A) FIRE was run on ‘non-discovery mode’ on a dataset of axonal transcriptome 
changes in response to Pum2 knockdown. The preferred version of the Pum2 PBE motif as 
well as the more common Pum1/2 PBE were tested. Yellow intensity corresponds to the degree 
of enrichment of a motif while blue intensity refers to the degree of depletion of a motif. The 
left bins contain mRNAs that are relatively enriched in cell bodies, while the right bins contain 
mRNAs that are relatively enriched in axons. Each bin contains about 200 mRNAs. (B) FIRE 
was run on two sets of mRNAs, one representing mRNAs whose expression did not change in 
axons upon shPum2, while the other is the set of mRNAs that were increased.   
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amount of Puromycin incorporation during 10 minutes. I found that knocking down Pum2 leads to 
about a 30% increase in total axonal translation (Figure 5.8). To test whether this effect was at least 
partly due to contributions of PBE containing mRNAs that were increased in axons I carried out a 
Puro-PLA assay for one of the target mRNAs, Gsk3β. This mRNA was increased 3 fold in axons 
upon Pum2 knockdown and was chosen for downstream analysis because of its known involvement 
in regulating several of the neurodevelopmental processes that seem to be associated with Pum2 









Figure 5.8: Pum2 downregulation increases overall axonal translation. Axons of DIV7 rat 
sensory neurons treated with shControl or shPum2 were labeled with puromycin for 10 mins to 
detect newly synthesized proteins and immunostained with α-Puromycin (red) and α-βIII 






Since Pum1 and Pum2 have an almost identical homology RNA binding domain they are 




Figure 5.9: Pum2 knockdown increases translation of Gsk3β in axons. Axonal Gsk3β 
translation was measured by using a Puro-PLA protocol (described in details in methods) (n=3 
biological replicates). Axons were immunostained with α-βIII Tubulin (green) and Puro-PLA 
signal (red). * p < 0.05.  
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several studies have reported specific biological dysfunction when either one is knockdown alone 
and, embryonic lethality when both are knockdown at the same time (Zhang et al., 2017). These 
findings suggest that while they may complement each other and even compensate for the absence 
or dysfunction of the other, their functions might not completely overlap. Surprisingly, I found the 
subcellular localization in neurons of Pum1 and Pum2 to be strikingly different. Pum2 was highly 
restricted to the cell body compartment, while Pum1 was enriched in axons. This subcellular 
expression pattern for Pum2 had previously been reported (Vessey et al., 2006) and, Pum1 had been 
found to be expressed pre-synaptically and Pum2 post-synaptically (Marrero et al., 2011). Moreover, 
I also found these two proteins to be differentially expressed during cortical development. 
Specifically, Pum2 expression peaks at the embryonic stage and then gradually declines during 
development. This finding has been confirmed recently in the mouse nervous system (Zhang et al., 
2017). Importantly, Pum2 subcellular and developmental expression patterns matches my previous 
findings regarding the PBE. 
 Several studies have now identified a similar cohort of axonally localized mRNAs. Similarly, 
I found that over 70% of the mRNAs localized in my RNA-Seq dataset overlap with prior described 
axonal transcriptome (Minis et al., 2014). This is very significant when taking into account that I 
utilized a different animal species, neuronal culturing method, and timing of axonal RNA extraction, 
suggesting a common underlying regulatory mechanism. Moreover, testing the significance of the 
PBE in neuronal mRNA localization on the naïve transcriptome produced the same result as 
previously obtained in the analysis of the Minis et al. (2014) dataset, providing more evidence for 
robust mRNA localization regulation mediated by the PBE.  
Until now, I had hypothesized that Pum2 could act at least through two mechanisms to 
account for the exclusion of PBE containing mRNAs from axons. First, Pum2 could act by lowering 
the mRNA stability and therefore half-life of target mRNAs resulting in their degradation before 
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reaching the axon. Such mechanism, had actually been proposed for Drosophila Pumilio (Burow et al., 
2015) where the PBE was associated with mRNA decay and enriched in neurogenesis regulating 
mRNAs and decreased in neurite localized mRNAs. The finding that mammalian Pum1/2 regulate 
neurogenesis was reproduced in the mouse nervous system (Zhang et al., 2017). But, unlike in 
Drosophila, Pumilio proteins did not affect mRNA stability and rather acted by regulating translation 
of target mRNAs. Similarly, I found that Pum2 did not regulate mRNA levels in neurons since 
knocking it down did not produce significant changes in the whole neuronal transcriptome. 
Therefore, it seems less likely that in mammalians Pum2 regulates mRNA localization by regulating 
mRNA stability. Importantly, Pum2 knockdown led to a significant increase in PBE containing 
mRNAs in axons suggesting a specific function for Pum2 as a neuronal mRNA localization 
regulator by somatic retention of target mRNAs. Mislocalized PBE containing mRNAs may then 
have caused an overall increase in axonal translation output as demonstrated by an increase in total 










Chapter 6. Pum2 dysfunction results in impaired axon growth, branching, and 
regeneration 
6.1. Rationale and Summary 
Pumilio proteins have been implicated in nervous system development. They have been 
shown to be important for dendritic morhogenesis, synaptic spine formation, neurogenesis, and 
protein toxicity induced neurodegeneration. Yet, the individual contributions and roles of each 
mammalian Pumilio homologue to neuron development has not been specifically addressed. Given 
my findings that Pum2 regulates axonal mRNA composition and translation in developing neurons, 
I hypothesized a role for Pum2 in axonal development. To address this experimentally, I decided to 
use in-utero electroporation to knockdown Pum2 in embryonic mice brains. The advantage of this 
technique over simply using a knockout mouse line is that allows for better temporal and spatial 
control of Pum2 knockdown. In collaboration with Dan Iascone, a graduate student in Franck’s 
Polleux laboratory at Columbia University, we observed that Pum2 is required for proper axonal 
extension and branching. 
 Axonal translation in response to nerve injury is important for axonal regeneration. Since, 
Pum2 knockdown alters the composition of axonal mRNAs, I expect axons to respond differently 
to axonal injury. I decided to use this system to study both the role of Pum2 and of axonal mRNA 
localization and translation in regulating axon regeneration.  I found that indeed axon regeneration is 
impaired when Pum2 is knockdown and that this might be due to the improper localization and 




6.2.1. Gene Ontology analysis of PBE containing mRNAs suggests a neurodevelopmental 
role for Pum2 
To gain biological insight as to the function of PBE containing mRNAs I ran a Gene 
Ontology analysis on the list of these mRNAs that are both expressed in the mouse and rat DRG 
neuron transcriptomes. The top overall biological functions as well are listed (FIGURE 6.1). Of 
particular interest to the context in which we are studying the PBE motif are: mRNA processing, 
nervous system development, dendrite morphogenesis, neuron projection development, axogenesis, 
axon extension, and axon guidance. Many of these categories are shared between both 
transcriptomes. Moreover, they also overlap with the enriched categories of somatically enriched 










Figure 6.1: PBE containing mRNAs are enriched in nervous system development 
categories. PBE containing mRNAs were identified with FIRE on developing mouse and rat 
sensory neurons transcriptomes previously mentioned. DAVID gene ontology website was used 






 6.2.2. Downregulation of Pum2 in-vivo results in impaired contralateral axon outgrowth and 
branching. 
I decided to study the consequences of disrupting the Pum2 regulation of PBE containing 
mRNAs localization during neuronal development in order to better understand the biological 
function of this regulatory process. We used an established in-utero electroporation protocol to 
knockdown Pum2 in a cortical hemisphere of a developing mice at an early stage (E15). We found a 
significant reduction in contralateral axonal crossing at P5 in the shPum2 condition (FIGURE 6.2. 
This suggests that Pum2 is required for during early axon extension. We then looked at the axonal 
projections to the contralateral hemisphere at P21 and found that knocking down Pum2 significantly 
impaired axonal targeting to the upper layers (FIGURE 6.3). Thus, Pum2 is required for proper 




















Figure 6.2: Pum2 knockdown results in decreased contralateral axon outgrowth. E15 
mouse brains were electroporated with shControl or shPumilio2 on a single hemisphere. 










Figure 6.3: Pum2 knockdown results in decreased contralateral axon branching. E15 
mouse brains were electroporated with shControl or shPumilio2 on a single hemisphere. 






6.2.4. Pum2 disruption results in impaired axon regeneration after injury 
 Axon mRNA localization and translation are tightly regulated in response to nerve injury to 
establish an appropriate axon regeneration program. Since my prior findings indicate that mRNA 
localization and translation is regulated by Pum2 I decided to test whether disrupting this pathway 
would influence axon regeneration. Axons of sensory rat neurons grown in microfluidic devices 
were injured by aspiration with a pipette in the axonal compartment. Axon outgrowth after 24 h 
under shControl and shPum2 conditions was measured revealing a significant decrease in 











Figure 6.4: Pum2 knockdown results in axon regeneration in-vitro. Axons from DIV5 rat 
sensory neurons grown in microfluidic devices were injured by aspiration. Axon regrowth was 







I conducted a gene ontology enrichment analysis for PBE containing mRNAs in sensory 
neurons which revealed ‘Neuron projection development’ as one of the most significant categories. 
A recent study that conducted CLIP-Seq of Pum1/2 in developing neurons also found this category 
as the second most significant in neuronal mRNA targets of Pum2 but not Pum1 (Zhang et al., 
2017). Together, with my finding that Pum2 controls axonal mRNA localization and translation 
there was a good indication to study the role of Pum2 in regulating axonal development. Indeed, I 
discovered that Pum2 is required for proper axon development in mouse neurons in-vivo. By 
knocking down Pum2 in the developing cortex in a single brain hemisphere I found that axon 
growth and branching to the contralateral side was impaired. That same study by Zhang et al. (2017) 
had found that Pum2 was required for neurogenesis and therefore many of the developmental 
effects that they observed were in part due to grow morphological defects during brain 
development. My approach to study the role of Pum2 in axon development offers some advantages 
due to a high spatiotemporal control of Pum2 knockdown which only occurs after neuron and axon 
specification and is restricted to one brain hemisphere. Therefore, increasing the confidence that any 
resulting phenotype is likely due to cell-autonomous dysfunction in developing axons that were 
already formed.   
For an axon to find the appropriate target in the contralateral hemisphere it must integrate 
complex signaling pathways that start by navigating through gradients of guidance cues which in 
turn drive responses depending on the fine spatiotemporal control of the expression of surface 
receptors. Local protein synthesis as well as degradation have been shown to be required during this 
process. One potential explanation then for the defects in contralateral outgrowth from knocking 
down Pum2 is due to dysregulation of axonal mRNA localization and translation. The overall effects 
observed were modest, it would be interesting to test whether Pum2 dysfunction equally and 
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gradually interferes with contralateral axon outgrowth across a broad class of cortical neurons or 
whether it has an ‘all or nothing’ effect on a specific subclass. Axon branching and arborization 
similarly requires the complex integration of signals and evidence suggests that localized translation 
plays a role its regulation. Specifically, mitochondrial function and cytoskeletal remodeling are 
modulated by local protein synthesis to respond to control branching.  
One major limitation of my approach is that currently is technically unfeasible or highly 
difficult to test the localized protein synthesis dependence of Pum2 mediated regulation of axon 
outgrowth and branching in-vivo. One interesting regulator of axon branching is Gsk3β, whose 
mRNA localization and translation is increased in axons upon Pum2 downregulation. Therefore, 
whether Pum2 exerts its function through this pathway could be tested by modulating the PI3K-
AKT-GSK3 signaling axis. Additionally, another signaling pathway that I found upregulated in 
axons upon Pum2 downregulation, and that we are currently studying, is MAPK signaling. Small 
changes in the localization and translation of these enzymes can easily lead to big downstream 
effects given how these enzymes are capable of signal amplification.  
Finally, axon regeneration after injury shares many of the signaling pathways and processes 
of developing axons. Specifically, Gsk3 signaling has been shown to modulate intrinsic axon growth 
capacity during regeneration. Moreover, axon injury induces specific recruitment of mRNAs which 
could be disrupted by Pum2 downregulation. Thus, it would be interesting to test how the axonal 
transcriptome in response to injury is affected by Pum2. The current experimental setup of carrying 
axon injury in microfluidic devices would also allow for the testing of local protein synthesis 





Chapter 7. Research Highlights: Significance and Future Directions  
This dissertation provides a conceptual advance in our understanding of neuronal mRNA 
localization and translation regulation. It highlights a novel filtering mechanism by which mRNAs 
containing a specific signal are excluded from axonal localization and translation during early 
neuronal development. It then demonstrates the importance of this regulatory process to achieve 
proper contralateral axon outgrowth and branching as well as during axon regeneration in response 
to nerve injury. This chapter outlines the major research highlights, their significance, and future 
directions. 
 
7.1. mRNA localization signals restrict axonal localization. 
Significance: 
A critical gap in our understanding of subcellular mRNA localization in neurons results from 
not knowing the extent to which localization elements globally contribute to the specificity and 
identity of localized mRNAs. In the case of axonal and dendritic mRNA localization, research has 
mostly focused on the role of localization elements in targeting a few mRNAs to their respective 
compartments. Such ‘positive’ localization elements have been the focus of much research although 
there has been difficulty in expanding and characterizing them more broadly. On the contrary, 
whether there exist ‘negative’ localization elements, opposing or restricting the axonal localization of 
an mRNA, has not been addressed. In my thesis work, I identified the PBE as a retention element 
that strongly restricts localization of mRNAs to the soma. This is the first time that an exclusion 
mechanism in the regulation of neuronal mRNA localization is reported. Although I focus on the 
PBE, my analysis reveals a broader pattern of regulated mRNA localization by retention since no 
‘positive’ localization element was found across several transcriptomes. The extent to which the 
PBE repressed the translation of specific mRNAs in axons changed during development suggesting 
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a mechanism for stage-dependent temporal control of axonal translation. Altogether, the novel 
finding that the PBE is restrictive of axonal mRNA localization provides new insights into the 
mechanisms that regulate mRNA targeting in neurons andconsequently, opens additional avenues 
for therapeutic targets as well as technical applications to the study and control of mRNA 
localization.  
Future Directions: 
A striking finding from my computational analysis is the absence of ‘positive’ localizing 
elements. While axonal mRNA localization might be strongly regulated through the exclusion of 
specific mRNAs, it is important to test whether current limitations in my computational analysis 
resulted in low sensitivity for the identification of other regulatory elements. Specifically, the search 
for regulatory elements in 3’UTRs is handicapped by the current status of their annotations. 
Recently, applying 3’end RNA-Seq to somatic and axonal mRNAs revealed that axonally localized 
mRNAs contain much longer 3’UTRs (Andreassi et al., 2017). Moreover, newly generated 3’UTR 
annotations from this study demonstrated that current annotations fall short of including whole 
3’UTRs. Importantly, they found localizing elements in mRNA isoforms containing the longer 
3’UTRs. Finally, this study as well as others (Taliaferro et al., 2016) have shown isoform specific 
3’UTRs to be exclusively localized in axons. Incorporating improved 3’UTRs annotations with 
isoform specific expression utilizing more in-depth RNA-Seq will increase the likelihood of finding 
‘positive’ localizing elements.   
  In addition to linear sequence motifs, RNA structure is known to control the binding of 
trans acting regulatory factors. Much less is known about the contribution of structural RNA motifs 
to mRNA localization in neurons. Utilizing computational algorithms to interrogate the 
contributions of structural RNA motifs to the genome-wide measurements of subcellular RNA 
localization would not only extend the number and type of localization elements but might result in 
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the discovery of novel trans-acting regulators. One such algorithm, Tool for Eliciting Informative 
Structural Elements in RNA (TEISER), has been successfully applied to discover structural elements 
and their associated trans-acting factors controlling transcript stability (Goodarzi et al., 2012, 2014) 
as well as in genome-wide post-transcriptional regulation (Oikonomou et al., 2014). Experimentally, 
newly identified structural, regulatory motifs can be used as ‘bait” to purify neuronal and axonal 
RNPs (Doron-Mandel et al., 2016). Altogether, a comprehensive characterization of the cis and 
trans-acting elements that regulate mRNA localization in neurons would allow researchers to predict 
the localization of specific mRNAs in a given system.  
PBE mediated somatic mRNA retention can be applied to study the role of axonally 
produced proteins in vivo. Currently, the best available tool to demonstrate the need and the 
function of localized translation is to apply RNAi locally and acutely. Unfortunately, this technique 
has several drawbacks and is more challenging to implement in vivo. Two alternate and 
complementary approaches to restrict the localization of specific mRNAs in neurons could be 
developed by either genetically adding PBEs to a 3'UTR of interest or by generating modular PUM 
binding domains that recognize specific sequence elements. Tightly controlling the induction and 
components of such system would be necessary, but its successful implementation could lead to 
insights as to the function of axonally synthesized proteins in vivo. 
In the last decade, many discoveries have highlighted the importance of non-coding RNAs 
in regulating multiple biological processes. The majority of studies of subcellular RNA localization in 
neurons have only focused on mRNAs. A comprehensive understanding of RNA localization will be 
incomplete without the inclusion of this abundant class of RNAs. It is not just essential to answer 
how their localization is regulated, but also how they might control mRNA localization as well. 
ncRNAs contain regulatory elements that can act as "sponges" by sequestering RBPs thus lowering 
their effective availability to target mRNAs. For example, the ncRNA NORAD contains multiple 
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PBEs through which it sequesters Pumilio proteins to regulate genomic stability (Lee et al., 2016). 
Finally, circular RNAs are an emerging subclass of ncRNAs that seem highly abundant and 
functional in the nervous system. There is already evidence that circRNAs are differentially localized 
in neuronal processes, but a genome-wide study of their subcellular localization in neurons is still 
needed (You et al., 2015).  
 
7.2. Pum2 restricts axonal mRNA localization of PBE containing mRNAs. 
Significance: 
 Studies of axonal mRNA localization have focused on the role of RBPs in positively 
targeting mRNAs into axons. It has been hypothesized that perhaps a gating mechanism exists that 
restricts the localization of mRNAs into axons (Jung et al., 2012). Here, I present the evidence for 
such a mechanism for the first time. As discussed earlier, mRNA retention can serve as a passive 
filter reducing stochastic errors in mRNA localization at a low energy cost for the cell. Moreover, I 
identified a novel role for Pum2 as a regulator of mRNA localization in neurons. In agreement with 
a recent study (Zhang et al., 2017) I found that Pum2 does not globally affect mRNA levels in 
neurons. This suggests that Pum2 mediated mRNA localization regulation is likely due to its 
exclusive expression in the somatic compartment compared to axons and not due to the control of 
mRNA stability as proposed in other systems (Burow et al., 2015).  
Future Directions: 
 I chose to focus on Pum2 since its expression and subcellular localization, as well as its 
slightly more flexible binding preferences, matched my computational findings better than Pum1. 
But, both RBPs are potentially able to bind the target mRNAs, and other studies have shown a 
considerable overlap between the two. It would be then essential to test whether Pum1 also 
contributes to restricting axonal mRNA localization or whether it has the opposite effect by 
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competing with Pum2. Since Pum1 is highly enriched in axons, unlike Pum2, it would have to 
decrease transcript stability or promote their degradation to restrict their expression in axons. 
Additionally, there is the question of how Pum1/2 mechanistically regulate mRNA localization. To 
address this issue, experiments to characterize the composition of neuronal Pum1/2 mRNPs by 
using high throughput techniques to sequence both the protein and mRNA components should be 
carried out. The findings from such experiments might also help explain how Pum1 and Pum2 
subcellular localization is being regulated.  
 
7.3. Pum2 is required for proper axon development and regeneration. 
Significance: 
 There is extensive evidence that the axonal localization and translation of specific mRNAs is 
required for proper axon development and maintenance. Here, I demonstrate more broadly the 
importance of adequately regulating axonal mRNA localization and translation globally by 
interfering with Pum2 function. I found a novel role for Pum2 in regulating contralateral axon 
extension and branching during cortical development presumably due to disruption of localized 
translation. Moreover, disrupting the axonal transcriptome by knocking down Pum2 impaired 
axonal regeneration in response to injury. Altogether, these findings suggest that the axonal 
transcriptome/translatome has to be tightly regulated for proper axon development and 
regeneration. Shigeoka et al. (2017) found targets of mTORC1 to peak in axonal translation at P0.5, 
the stage of axon wiring. This is not surprising given that the mTORC1 is strongly linked to the 
regulation of axonal translation (Campbell and Holt, 2001) and axonal branching (Spillane et al., 
2013). Interestingly, at this stage, I found the highest repression of Pum2 targets in axons. Knocking 
down Pum2 increased the mRNA levels in axons of mRNAs that encode for known inhibitors of 
mTOR signaling such as Gsk3β and members of the MAPK signaling family. Thus, Pum2 
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morphological effects on axon development and regeneration could be explained by it having a 
broader function in modulating mTOR activity.  
Future Directions: 
 Several roles have been ascribed to Pum2 during nervous system development and 
maintenance, yet the specific mechanisms by which Pum2 exerts its functions have not been 
characterized in detail. Although Pum2 has been broadly described as a translational repressor, the 
specific mRNA targets and signaling pathways that it regulates during neurodevelopment have not 
been identified. In this thesis work, I provided a first step towards the goal of increasing our 
understanding of the downstream mechanisms by which Pum2 acts by identifying the cohort of 
mRNAs that are mislocalized in axons as a result of its dysfunction. Going forward, I propose to 
test the way in which these changes in the axonal transcriptome disrupts the signaling mechanisms 
that are required for proper axon outgrowth, branching, and regeneration. As mentioned above, 
mTOR regulated mRNA translation plays a vital role in these processes, and some of the mRNA 
targets that are upregulated in axons upon Pum2 knockdown are modulators of mTOR signaling. 
Thus, I propose to study in more detail how components of mTOR are changed after interfering 
with Pum2 function and in response to nerve injury. If these elements are indeed changed, then 
pharmacological or molecular tools should be used to restore them in an attempt to rescue the 
morphological phenotypes observed. Two specific mRNA targets that were identified in the 
transcriptome and that should be evaluated are Gsk3β and Mapk6 both of which are involved in the 
regulation of axon growth and regeneration under physiological conditions. 
 
7.4. Closing Statement 
Collectively, this dissertation demonstrates a role for Pum2 in the regulation of neuronal mRNA 
localization by the exclusion of target mRNAs from axons during development. This novel 
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molecular filter is important as its disruptions leads to axon growth and branching defects as well as 
impaired regeneration after injury. My research findings highlight the importance of regulating 
axonal mRNA localization and localized protein synthesis in the nervous system. Future work 
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Local synthesis of dynein cofactors matches
retrograde transport to acutely changing demands
Joseph M. Villarin1, Ethan P. McCurdy2, Jose´ C. Martı´nez1 & Ulrich Hengst3,4
Cytoplasmic dynein mediates retrograde transport in axons, but it is unknown how its
transport characteristics are regulated to meet acutely changing demands. We find that
stimulus-induced retrograde transport of different cargos requires the local synthesis of
different dynein cofactors. Nerve growth factor (NGF)-induced transport of large vesicles
requires local synthesis of Lis1, while smaller signalling endosomes require both Lis1 and
p150Glued. Lis1 synthesis is also triggered by NGF withdrawal and required for the transport of
a death signal. Association of Lis1 transcripts with the microtubule plus-end tracking protein
APC is required for their translation in response to NGF stimulation but not for their axonal
recruitment and translation upon NGF withdrawal. These studies reveal a critical role for local
synthesis of dynein cofactors for the transport of specific cargos and identify association with
RNA-binding proteins as a mechanism to establish functionally distinct pools of a single
transcript species in axons.
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any cellular functions rely on the ordered transport
of macromolecules, proteins and organelles. Most
intracellular transport is an active process mediated
by motor protein complexes that move their cargos along
components of the cytoskeleton: myosins transport cargos along
actin filaments, while microtubule-based transport is facilitated
by two families of motors, the plus-end directed kinesins and
minus-end directed dynein1. In contrast to the great variety of
myosins and kinesins, there is only a single cytoplasmic dynein,
which is complemented by an array of regulatory proteins to fulfil
different functions2. These multifunctional proteins bind either to
the non-catalytic domains of dynein or directly to its force-
generating heavy chain, thereby changing the characteristics of
the dynein motor. For example, Lis1 (gene: PAFAH1B1) induces a
persistent force-producing state in microtubules-attached,
moving dynein by acting as a clutch linking the ATPase and
microtubules-binding domains3,4. It maintains the microtubule-
bound state of dynein5, and is required for moving large vesicles
through a constraint environment with high drag forces such as
kinked axons6. Together with NudE, it enhances the sustained
force produced by the dynein motor in a load induced manner7.
In addition, axonal Lis1 has been described as an initiation factor
for dynein-mediated transport8. Another dynein regulator,
dynactin, is a large complex of eleven protein subunits, with
p150Glued, encoded by DCTN1, being the largest and most
important. Among several described functions, dynactin acts by
increasing the processivity of the dynein motor9 and facilitates its
binding to different cargos10. Importantly, dynactin and Lis1
competitively bind the same domain of dynein11, suggesting a
mutually exclusive regulation of dynein by these adaptors. Thus,
cofactors or adaptor proteins such as dynactin or Lis1 regulate
dynein-dependent transport, but it remains unknown how their
association with dynein is controlled in a spatially precise and
temporally acute manner in response to extracellular signals. This
question is especially relevant in axons, where essentially all
microtubules are unidirectionally oriented with their plus-ends
facing the cellular periphery12, and dynein is anterogradely
transported as cargo by kinesins13,14. A potential solution to this
question is the on-demand, local synthesis of dynein cofactors
within distal axons and growth cones.
Intra-axonal protein synthesis is crucial for axon
development15–18, maintenance19, synapse formation20 and
axo-somatic communication21, as well as for axonal
regeneration22 and neurodegeneration23. From these studies,
a picture emerges in which local protein synthesis provides
short-lived and spatially precise bursts of locally translated
proteins, to react to extracellular cues, injurious insults or other
changes in an axon’s environment24. Therefore, it is especially
interesting that messenger RNAs (mRNAs) coding for dynein
regulators, including Lis1 and p150Glued, have repeatedly been
found in axons both in the central and peripheral nervous
system23,25,26.
Here we asked whether local synthesis of dynein regulators was
a mechanism to acutely match the intra-axonal retrograde
transport capabilities to changes in demand, as, for example, in
response to changes in extracellular trophic support. We report
that axonal synthesis of Lis1 and p150Glued is required for
the adjustment of retrograde transport to acutely changing
neurotrophin signalling in the periphery of neurons.
Results
NGF-induced changes in retrograde transport require translation.
To investigate whether changes in intra-axonal transport required
local protein synthesis, rat embryonic dorsal root ganglion (DRG)
were grown in tripartite microfluidic chambers that allow fluidic
isolation of distal axons from neuronal cell bodies and dendrites,
providing an experimental platform to study localized signalling
events in axons (Fig. 1a)17,27. We first investigated the requirement
of axonal protein synthesis for axonal retrograde transport in DRG
neurons kept at a low nerve growth factor (NGF) concentration of
5 ngml 1 that is sufficient to support their survival. Application of
protein synthesis inhibitors, anisomycin or emetine, did not change
the proportion of retrogradely moving LysoTracker-positive
particles, which in axons are mainly late endosomes and
autophagosomes (Fig. 1b)28. Because transport in the 5 ngml 1
NGF condition was protein synthesis independent, we decided to
use it as the baseline NGF concentration and to investigate whether
NGF withdrawal (0 ngml 1) or stimulation (100ngml 1)
changed the transport of LysoTracker-positive particles in a
protein synthesis-dependent manner. Upon NGF withdrawal or
stimulation, retrograde transport of LysoTracker-positive vesicles
was significantly increased with a corresponding decrease in the
proportion of stationary vesicles (Fig. 1c,d; Supplementary
Movies 1–5), while the percentages of anterogradely or
bidirectionally moving particles were not significantly changed
with either NGF concentration. Inhibition of protein synthesis
completely abolished the increases in retrograde transport upon
NGF stimulation and, surprisingly, upon NGF withdrawal.
Activation of protein synthesis had before only been described in
response to NGF stimulation17,18,21,29,30, but not depletion. To
investigate our finding that increased retrograde transport of
LysoTracker-positive vesicles in NGF-deprived axons was sensitive
to protein synthesis inhibition, we performed immunofluorescence
against a marker of active protein synthesis, the phosphorylated
form of 4EBP1 (Fig. 1e). The ratio of phosphorylated 4EBP1 was
significantly increased within distal axons upon 10min of NGF
stimulation as well was withdrawal. Inhibition of mTOR with
locally applied rapamycin completely abolished these changes.
To directly visualize local protein synthesis in response to changes
in NGF concentrations, we performed puromycylation assays.
Puromycin is a transfer RNA mimetic that gets incorporated into
nascent polypeptides and can be detected with specific
antibodies31. NGF withdrawal and stimulation significantly
increased the number of puromycylation events in axons in a
protein synthesis inhibitor-sensitive manner, confirming that local
protein synthesis is activated by both NGF stimulation and
depletion (Fig. 1f). Puromycylation in the cell bodies was not
affected by changes in NGF concentration or the addition of
protein synthesis inhibitors in the axon compartment further
proving the local nature of the NGF-induced changes in protein
synthesis (Fig. 1g). These results establish that while constitutive,
unstimulated retrograde transport does not require local protein
synthesis, rapid increases in dynein-dependent transport of
LysoTracker-positive particles in response to either NGF
stimulation or withdrawal are mediated by axonally produced
proteins.
NGF stimulation or withdrawal affect Lis1 and p150Glued.
mRNAs coding for regulators of cytoplasmic dynein have been
found in several axonal transcriptomes (Fig. 2a)23,25,26. To
investigate which proteins might be locally synthesized in
response to NGF stimulation or withdrawal, we focused on Lis1
and p150Glued. To directly visualize their mRNAs, Pafah1b1 and
Dctn1 within axons of DRG neurons, we used fluorescence in situ
hybridization (FISH). Both mRNAs were readily detectable in a
punctate pattern in axons and with significantly higher intensity
than the one obtained with a Gfp control probe (Fig. 2b). Using
quantitative immunofluorescence, we found that the axonal
abundance of Lis1 protein was significantly increased upon both
NGF stimulation and withdrawal for 10min (Fig. 2c), while in
contrast p150Glued levels were elevated only in response to NGF
stimulation (Fig. 2d). The levels of each protein were not changed
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by pre-incubation with protein synthesis inhibitors under
baseline conditions, but the increases in abundance upon NGF
stimulation (for both Lis1 and p150Glued) or withdrawal (Lis1
only) were abolished by the application of anisomycin or emetine
to the axonal compartment. Together, these data indicate that the
axonally localized transcripts of Lis1 and p150Glued might be
translated in response to changes in NGF signalling.
NGF signalling controls local Lis1 and p150Glued synthesis. To
directly test whether changes in axonal NGF signalling trigger the
local synthesis of Lis1 and p150Glued, we selectively transfected
axons with siRNAs targeting their mRNAs Pafah1b1 or Dctn1,
respectively, or with a non-targeting control siRNA. We had
validated the siRNAs by transfecting them into rat C6 glioma cells
and immunoblotting whole-cell lysates for Lis1 and p150Glued.
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Two siRNAs against each transcript were tested individually and
showed consistent phenotypes; the siRNAs were most efficacious
when used together (Supplementary Fig. 1). Previously, we have
demonstrated that the RNA interference (RNAi) pathway is
functional in developing axons32, and that it is possible to
selectively knockdown an mRNA in axons by local siRNA
transfection without causing a decrease of the transcript’s
abundance in cell bodies17,18,23,33. We confirmed that the
effects of the local siRNA transfections were indeed restricted
to axons by quantitative immunofluorescence against Lis1 and
p150Glued on cell bodies whose axons had been transfected with
siRNAs. No decrease of either protein was detectable in the
neuronal soma (Fig. 3a,b). In the siRNA-transfected axons, the
protein levels were not significantly reduced at our baseline NGF
concentration, again indicating that the mRNAs are not locally
translated under this condition (Fig. 3c,d). Conversely, the
significant increases in Lis1 abundance in response to NGF
stimulation or withdrawal were completely abolished by local
siRNA application, as was the increase in p150Glued levels in
NGF-stimulated axons. Together, these results demonstrate
that both transcripts can be locally translated in axons, but the
intra-axonal synthesis of these two dynein cofactors is
differentially regulated by changes in NGF signalling.
Lis1 synthesis is required for NGF-induced vesicle transport.
To determine whether the local synthesis of Lis1 and p150Glued in
response to changes in NGF concentration impacted retrograde
transport in axons, we incubated axons with LysoTracker and
scored the motility of labelled vesicles as before. Axonal knock-
down of Pafah1b1 or Dctn1 did not significantly affect retrograde
transport in the baseline condition (Fig. 4a), in line with our
finding that neither protein is locally synthesized under baseline
conditions. Axon-specific knockdown of Pafah1b1 abolished the
significant increase in the proportion of retrogradely moving
vesicles caused by NGF deprivation (Fig. 4b; Supplementary
Movie 6), and it caused a reduction of retrogradely moving
LysoTracker-positive particles below the baseline levels in the
NGF-stimulated condition (Fig. 4c; Supplementary Movie 7). In
contrast, knockdown of axonal Dctn1 mRNA did not affect the
movement of LysoTracker-positive vesicles upon either NGF
stimulation of withdrawal. Together, these results demonstrate
that locally synthesized Lis1 is required for induced retrograde
movement of these LysoTracker-labelled cargos, but p150Glued is
not. This observation is reminiscent of the finding that, globally,
high load retrograde transport requires Lis1 (ref. 6).
NGF–endosome transport requires Lis1 and p150Glued synthesis.
To investigate whether the requirement for local synthesis of
dynein cofactor varied between different cargos, we next visua-
lized the retrograde transport of NGF-signalling endosomes34.
Upon binding of NGF to its receptor TrkA, the receptor–ligand
complex is internalized, and the resulting endosome is
transported with downstream effector complexes to the soma
by a dynein–dynactin complex35. Mouse 2.5S NGF was linked
to red fluorescent quantum dots (QDs)36, selectively
applied to axons (100 ngml 1), and movement of QD-labelled
NGF-signalling endosomes was measured by live-cell microscopy
(Fig. 4d). The proportion of retrogradely moving particles seen
under naive and control siRNA conditions (B27%) was
consistent with previous studies37,38. Axon-specific knockdown
of Pafah1b1 or Dctn1 significantly reduced the retrograde
movement of QD-positive particles and increased the
proportion of stationary particles. Together, these results
establish that NGF stimulation triggers local synthesis of Lis1
and p150Glued, and that the stimulated transport of different
cargos requires the local synthesis of different regulator proteins.
Transport of an axonal death signal requires Lis1 synthesis.
According to the signalling endosomes hypothesis, transport of
NGF bound to activated tyrosine receptor kinases in endosomes
from axons to the cell body is required for the survival of neurons
dependent upon target-derived neurotrophic support35,39, while
another model proposes that NGF acts by suppressing a
retrograde apoptotic signal, and that retrograde transport of
NGF-signalling endosomes is not required for survival40. Because
of the observed reduction in retrogradely moving, QD-labelled
NGF-signalling endosomes upon axon-specific knockdown of
Pafah1b1 or Dctn1 mRNAs, we next tested whether survival of
the DRG neurons was impaired as well. NGF was withheld from
both compartments or selectively applied (100 ngml 1) to the
axonal compartment. To quench any residual NGF activity in the
deprivation conditions, a neutralizing anti-NGF antibody was
added. Contrary to what the signalling endosomes hypothesis
would predict but in line with a suppressive effect of NGF on an
axonal apoptotic signal in starved axons, in the NGF-replete
condition axonal knockdown of either Pafah1b1 or Dctn1 did not
induce apoptosis, as assessed by TUNEL-positive nuclei, nor did
it reduce the number of living neurons stained by calcein
acetoxymethyl (AM) (Fig. 5a,b). Moreover, in the NGF-starved
condition, knockdown of Pafah1b1 completely prevented the
induction of cell death by NGF deprivation. Knockdown of Dctn1
in the NGF-starved condition did not impact cell death,
consistent with our finding that NGF withdrawal does not
activate p150Glued synthesis.
Together, these results demonstrate that, although inhibition of
local Lis1 and p150Glued synthesis greatly reduced retrograde
transport of NGF-signalling endosomes, their local production is
Figure 1 | Local protein synthesis mediates NGF-regulated changes in axonal transport. (a) Representation of a microfluidic chamber used to isolate
axons. DRG neurons are seeded in the cell body compartment (green), and the axons extend through two microgroove barriers (blue) into the axonal
compartments (orange). All axon-specific treatments were applied to both axonal compartments, and analyses were performed in the distal most
compartment. (b–d) DRG neurons were cultured in microfluidic chambers for 3 DIV, at which point the NGF concentration in the axonal chamber
was changed to 5 ngml 1 for 24 h. On DIV 4, axons were pretreated with protein synthesis inhibitors (anisomycin and emetine) or vehicle
(dimethylsulphoxide, DMSO) for 2 h before application of medium containing the inhibitors or DMSO and either 5 ngml 1 NGF (b), no NGF (c), or
100ngml 1 NGF (d) and LysoTracker Green for 15min. Live-imaging time-lapse series of axonal fields were acquired, with images being taken every 13 s
for 4min. Kymographs of representative 100-mm-long axonal segments are shown. Scale bar, 10mm. LysoTracker-positive particles with diameters Z1mm
were scored as anterograde, retrograde, bidirectional or stationary. Percentage point differences to baseline condition are plotted. Data represent the
means±s.e.m. of nine fields per conditions (n¼ 3 biological replicates). *Pr0.05; **Pr0.01; ***Pr0.001. One-way ANOVA with Bonferroni’s multiple
comparison test. (e) DRG neurons were cultured as in b. After 10min of different NGF treatments, axonal levels of 4EBP1 and p-4EBP1 were determined by
immunofluorescence. Scale bar, 5 mm. Data represent the means±s.e.m. of 15 fields per conditions (n¼ 3 biological replicates). *Pr0.05; ***Pr0.001.
Two-way ANOVA with Dunnett’s multiple comparison test. (f,g) DRG neurons were cultured and axons were treated with NGF and inhibitors as in b.
Puromycin was added to all compartments of the chambers during the NGF treatment period. *Pr0.01; ***Pr0.001. Two-way ANOVA with Bonferroni’s
multiple comparison test. Scale bars, 10mm. NS, not significant.
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Figure 2 | NGF signalling differentially regulates Lis1 and p150Glued levels in axons. DRG neurons were cultured and treated as in Fig. 1. (a) Transcripts
coding for dynein regulators have been found in transcriptomes derived from embryonic rat DRG axons using microarray, embryonic mouse DRG using
RNAseq and embryonic rat hippocampal axons using RNAseq. Transcripts found in all three studies are highlighted in red, and Lis1 and p150Glued are
outlined in blue. (b) Pafah1b1 and Dctn1 levels were measured by quantitative FISH in axons kept for 12 h at the baseline NGF level (5 ngml 1). Background
fluorescence was determined using a Gfp probe and subtracted. Means±s.e.m. of 15 optical fields per condition (n¼ 3 biological replicates). *Pr0.05;
**Pr0.01. Kruskal–Wallis test with Dunn’s multiple comparison test. (c) Axons were pretreated with protein synthesis inhibitors (anisomycin and emetine)
or vehicle, followed by exposure to different concentrations of NGF (0, 5 or 100ngml 1) for 10min. Axonal Lis1 levels were measured by quantitative
immunofluorescence. Means±s.e.m. of 15–20 optical fields per conditions (n¼ 3–4 biological replicates). *Pr0.05. Two-way ANOVA with Dunnett’s
multiple comparison test. (d) Neurons were cultured and treated as in b. Axonal p150Glued levels were measured by quantitative immunofluorescence.
Means±s.e.m. of 15 optical fields per conditions (n¼ 3 biological replicates). *Pr0.05. Two-way ANOVA with Dunnett’s multiple comparison test.
Scale bars, 5mm. NS, not significant.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms13865 ARTICLE



































































































































































































































Figure 3 | NGF induces local synthesis of Lis1 and p150Glued. DRG neurons were cultured in microfluidic chambers. On DIV 3, the NGF concentration in
the axonal chamber was changed to 5 ngml 1, and axons were selectively transfected with a non-targeting control siRNA or siRNAs targeting Pafah1b1 or
Dctn1. (a,b) Twenty-four hours after transfection, axons were treated with 0, 5 or 100 ngml 1 NGF for 10min, and Lis1 (a) and p150Glued (b) levels in the
cell bodies were determined by immunofluorescence. Means±s.e.m. of 15 optical fields per conditions (n¼ 3 biological replicates). No significant changes.
Two-way ANOVA with Dunnett’s multiple comparison test. Scale bars, 20mm. (c,d) Neurons were cultured and treated as before, and axonal Lis1 (c) and
p150Glued (d) levels were determined by immunofluorescence. Scale bars, 5 mm. Means±s.e.m. of 20–75 optical fields per conditions (n¼4–15 biological
replicates). *Pr0.05; **Pr0.01; ***Pr0.001. Two-way ANOVA with Dunnett’s multiple comparison test. See also Supplementary Fig. 1. NS, not
significant.
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not required for NGF-dependent survival. Rather, local Lis1
synthesis is necessary for the retrograde transport of a
pro-apoptotic signal of unknown identity that is generated in
NGF-deprived axons40,41. To further characterize this retrograde
death signal ,we first focused on protein kinases that have been
implicated in apoptotic cell death in neurons. Whole-cell
treatment with inhibitors of mixed lineage kinases or p38 MAP
kinase has previously been shown to prevent neuronal apoptosis
induced by neurotrophin deprivation42,43, but application of
these inhibitors to axons alone did not interfere with induction of
apoptosis in NGF-deprived DRGs, suggesting that these kinases
act centrally rather than in the periphery (Fig. 5c). GSK3b had
been proposed as a carrier of the axonally generated apoptotic
signal40. Application of two GSK3 inhibitors, LiCl or SB216763
(ref. 44), selectively to axons had no effect on cell death under
NGF-replete conditions, but completely prevented the induction
of apoptosis with NGF deprivation (Fig. 5c). Together, these
results indicate that the death signal, whose transport requires
local Lis1 production, involves active GSK3b.
NGF signalling regulates axonal Pafah1b1 and Dctn1 levels. In
regenerating DRG axons, neurotrophins regulate the abundance
of specific mRNAs through anterograde recruitment from the cell
body45. To investigate whether changes in neurotrophin
signalling not only differentially regulate the translation of
axonally localized Pafah1b1 and Dctn1 mRNAs but also their
abundance, we performed quantitative FISH on axons selectively
transfected with siRNAs and treated with different NGF
concentrations. As before, the effect of the siRNAs was
restricted to axons as neither mRNA’s abundance in the
neuronal cell bodies was changed upon axonal siRNA
transfection (Fig. 6a,b). Quantification of the axonal FISH
signals revealed that neither mRNA was recruited in response
to stimulation with NGF, but that NGF deprivation caused a
significant increase in Lis1 transcript levels (Fig. 6c,d). Similar
results were obtained for FISH against the transcripts of NudE
and its paralogue NudEL, two proteins can form a trimeric
complex with dynein and Lis1 (Supplementary Fig. 2)46,
indicating that NGF might co-regulate mRNAs of proteins that
frequently function in a complex. The FISH signal was specific for
the targeted mRNAs as transfection of axons with siRNAs
targeting either transcript reduced the FISH signal to background
levels. The results of the FISH experiments were confirmed by
quantitative real-time PCR with reverse transcription (RT–PCR)
performed on RNA collected from axonal compartments
(Fig. 6e). The siRNAs failed to reduce the levels of their target
transcripts under NGF conditions that do not trigger the
translation of these mRNAs (baseline for both mRNAs; NGF
withdrawal for Dctn1). This effect is likely due to the tight
packaging in RNA granules of silenced mRNAs in axons47
rendering them inaccessible for the RNAi machinery, an effect
we had observed previously23. Together, these results
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Figure 4 | NGF-induced changes in axonal trafficking require local
synthesis of Lis1 or p150Glued. DRG neurons were cultured in microfluidic
chambers. On DIV 3, the NGF concentration in the axonal chamber was
changed to 5 ngml 1, and axons were selectively transfected with a
non-targeting control siRNA or siRNAs targeting Pafah1b1 or Dctn1.
(a–c) After 24 h, fresh medium was added to the axonal chamber
containing 5 ngml 1 NGF, no NGF or 100ngml 1 NGF together with
LysoTracker Green for 15min. Live-imaging time-lapse series of axonal fields
were acquired, with images being taken every 13 s for 4min. Kymographs of
representative 100-mm-long axonal segments are shown. Scale bar, 10mm.
LysoTracker-positive particles with diameters Z1mm were scored as
anterograde, retrograde, bidirectional or stationary. Means±s.e.m. of 12–18
optical fields per conditions (n¼ 3–6 biological replicates). **Pr0.01;
***Pr0.001. One-way ANOVA with Bonferroni’s multiple comparisons
test. (d) On DIV 4, axons were treated with 100 ngml 1 QD-NGF for
15min and live imaged as above. QD-labelled particles o1-mm diameter
were scored as anterograde, retrograde, bidirectional or stationary.
Means±s.e.m. of nine optical fields per conditions (n¼ 3 biological
replicates). **Pr0.01; ***Pr0.001. Kruskal–Wallis test with Dunn’s
multiple comparison test. NS, not significant.
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cofactors Lis1 and p150Glued is differentially regulated both
translationally and through recruitment of their mRNAs.
APC-binding sorts Pafah1b1 into functionally distinct pools.
The finding that the one mRNA species, Pafah1b1, is locally
translated in response to both NGF stimulation and withdrawal,
and, further, is recruited into axons only upon NGF deprivation
but not stimulation, strongly suggested that distinct regulatory
mechanisms exist that control Pafah1b1 localization and
translation under different signalling conditions. Recently,
Pafah1b1 has been found to be part of the adenomatous polyposis
coli (APC) interactome48. APC is a microtubules plus-end
tracking protein, also referred to as þTIP49, and by binding a
specific subset of mRNAs, APC might provide a platform for the
local synthesis of dynein regulators, including Lis1, at the distal
end of axonal microtubules. Thus, we wondered whether
association with APC was required for Pafah1b1 regulation in
axons. To address this question, we used a locked nucleic acid
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Figure 5 | Pro-apoptotic signalling from NGF-deprived axons requires axonally synthesized Lis1 and active GSK3b. (a) DRG neurons were cultured and
transfected with siRNAs as in Fig. 4. On DIV 4, the medium in the somatic compartment was changed to NGF-free medium containing NGF-neutralizing
antibody, and axonal compartments were changed to 100ngml 1 NGF or NGF-free medium with NGF-neutralizing antibody plus vehicle for 24 h. Cell
death was assessed by TUNEL assay. Means±s.e.m. of 15–25 optical fields per conditions (n¼ 3–5 biological replicates). ***Pr0.001. Two-way ANOVA
with Dunnett’s multiple comparison test. (b) Neurons were cultured and treated as in a. Survival was assessed by calcein AM staining. Means±s.e.m. of 15
optical fields per conditions (n¼ 3 biological replicates). ***Pr0.001. Two-way ANOVA with Dunnett’s multiple comparison test. (c) DRG neurons were
cultured as in Fig. 4. On DIV 4, the medium in the somatic compartment was changed to NGF-free medium containing NGF-neutralizing antibody, and the
medium in the axonal chamber was changed to 100ngml 1 NGF or NGF-free medium with NGF-neutralizing antibody plus the mixed lineage kinase
inhibitor, CEP-1347, the p38 MAP kinase inhibitor, SB239063, or the GSK3b inhibitors, LiCl or SB216763, or vehicle for 24 h. Cell death was assessed by
TUNEL assay. Means±s.e.m. of 15–25 optical fields per conditions (n¼ 3–5 biological replicates). ***Pr0.001. Two-way ANOVA with Dunnett’s multiple
comparison test. Scale bars, 20mm. NS, not significant.
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Figure 6 | NGF signalling regulates axonal transcript levels of dynein regulators. (a–d) DRG neurons were cultured in microfluidic chambers for 3 DIV, at
which time the NGF concentration in the axonal chamber was changed to 5 ngml 1, and axons were selectively transfected with a non-targeting control
siRNA or siRNAs targeting Pafah1b1 (a,c) or Dctn1 (b,d). Twenty-four hours after the transfection, the NGF concentration in the axonal chamber was
adjusted to 0, 5 or 100ngml 1 NGF for 12 h, and cell body Pafah1b1 (a) or Dctn1 (b) or axonal Pafah1b1 (c) or Dctn1 (d) mRNA levels were determined by
FISH. Means±s.e.m. of 15–25 optical fields per condition (n¼ 3–5 biological replicates). *Pr0.05; **Pr0.01; ***Pr0.001. Two-way ANOVA. Scale bars,
20mm (a,b); 5mm (c,d). (e) Neurons were cultured and axons treated with NGF in microfluidic chambers as before. Axonal RNAs were collected after the
12 h NGF treatment, and Pafah1b1 and Dctn1 levels were determined by quantitative real-time RT–PCR. Relative quantification with Gapdh as reference was
done using the 2DDCTmethod. The means of the 5 ngml 1 NGF conditions for Pafah1b1 and Dctn1 were defined as 1.0. Means±s.e.m. of 3–5 biological
replicates. *Pr0.05. Kruskal–Wallis test with Dunn’s multiple comparison test. NS, not significant.
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association by binding the putative APC-binding site, a CUGU
motif in the 30-untranslated region (UTR) of Pafah1b1 (ref. 48).
To determine which of the several CUGU motifs in the 30-UTR of
Pafah1b1 to target, reads from the APC-CLIP study48 were
collapse and quality-filtered50 and mapped to the mouse genome
(mm10). Mapped reads were analysed for cluster enrichment
using PIPE-CLIP51. Three clusters in the 30-UTR of Pafah1b1
were found to be significantly enriched in APC-binding, but only
two of these clusters had a significant fold change compared with
a control mRNA-seq data set. We chose the cluster with the
lowest P value (1.41 10 11), which also contained a CUGU
motif. A second LNA, binding Pafah1b1 13 bases upstream of the
CUGU LNA, was used as a control (Fig. 7a). To confirm whether
the CUGU LNA was able to interfere with APC–Pafah1b1
interaction, we transfected the LNAs in dissociated DRG and
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detectable in the precipitate and its abundance reduced in RIPs
from CUGU LNA-transfected DRGs (Fig. 7b). Next, the LNAs
were transfected in the cell body compartment, and mRNA levels
in axons were determined by quantitative FISH 12 h after
different NGF treatments as before (Fig. 7c). The control LNA
had no discernible effect compared with naive axons (two-way
analysis of variance (ANOVA) P¼ 0.7585), while transfection
with the CUGU LNA caused reduced Pafah1b1 levels in all
three conditions (P¼ 0.008). The differences in Pafah1b1
abundance at 5 and 0 ngml 1 or 0 and 100 ngml 1 NGF
were significant in both naive and CUGU LNA-transfected axons
and extremely similar (5 and 0 ngml 1: 0.56 versus 0.50; 0 and
100 ngml 1: 0.58 versus 0.68). These results indicate that APC
association is required for the axonal localization of a fixed
amount of Pafah1b1, but that the recruitment of additional
Pafah1b1 into axons in response to NGF withdrawal is APC-
independent.
To determine whether Lis1 protein levels in axons were
similarly affected by interference with Pafah1b1–APC binding,
we transfected DRGs with LNAs as before and performed
quantitative immunofluorescence against Lis1 (Fig. 7d). No
significant change in Lis1 abundance was detected at 5 ngml 1
NGF, again confirming that it is not locally synthesized under this
condition. The increase in axonal Lis1 abundance in CUGU
LNA-transfected DRGs at 0 ngml 1 was indistinguishable from
naive and control LNA neurons, while in NGF-stimulated axons
transfection with the CUGU LNA prevented the increase in Lis1
levels.
Finally, we investigated the requirement of Pafah1b1–APC
association for stimulation-induced retrograde transport of
LysoTracker-positive cargos. Transfection of the CUGU LNA
had no effect on transport at the baseline NGF condition or upon
NGF withdrawal, but completely prevented the increase in
retrograde transport triggered by NGF stimulation (Fig. 7e–g).
Together, the results from the LNA experiments reveal the
existence of two distinct modes of Pafah1b1 localization in axons:
one that is constitutively active and APC-dependent, and other
that is APC-independent and particularly responsive to NGF
deprivation (Supplementary Fig. 3). The transcripts that are
localized in the APC-dependent mode are translated in response
to stimulation with NGF, while the APC-independent pool is
locally translated with NGF withdrawal and is boosted by
recruitment into NGF-starved axons. Thus, the two diametrically
opposed triggers of axonal Lis1 synthesis, NGF withdrawal and
stimulation, act on two separate pools of Pafah1b1 mRNA that
each are solely responsible for the increase in local Lis1 levels
under either condition.
Discussion
Association with various accessory proteins allows cytoplasmic
dynein to fulfil a multitude of functions in cells and to transport a
wide variety of different cargos. Here we provide evidence that in
distal axons, stimulus-induced changes in dynein-dependent
transport are regulated through local synthesis of Lis1
and p150Glued. The unidirectional nature of microtubules in
axons poses special challenges for the acute regulation and
initiation of dynein-dependent transport, and local translation of
its cofactors can solve this problem. As the unidirectional
orientation of microtubules is not unique to axons but occurs
also in distal dendrites or during neuronal cell migration, it is
possible that this mechanism is utilized in these circumstances
as well. Meanwhile, local synthesis of motor complex proteins
might not be restricted to Lis1 and p150Glued. p150Glued is
only one of several subunits of dynactin. The transcript for
another subunit, p50, is also consistently found in transcriptomes,
while the localization of transcripts coding for other subunits is
less clear. It remains unknown whether the entire dynactin
complex can be locally synthesized or whether it locally assembles
upon on-demand synthesis of p150Glued and potentially p50.
Changes in intra-axonal transport have long been recognized
as hallmarks of many neurological and neurodegenerative
disorders52,53. In addition, alterations in neurotrophin signalling
have been implicated in neurodegenerative and psychiatric
disorders54. Therefore, it will be important to investigate
whether the processes uncovered here are disrupted in disease
and whether they might present novel targets for therapies. For
example, our previous finding that soluble oligomeric Ab1–42
upregulates protein synthesis in axons of mature hippocampal
neurons23 indicates the possibility that local translation has an
impact on dynein-dependent transport in Alzheimer’s disease
brain.
It is worth noting that axonal production is not merely
supplementary to global synthesis of these dynein cofactors.
Neuron-wide knockdown of Lis1 expression reduces retrograde
stimulation-independent transport of LysoTracker-positive
vesicles in axons55, while we found that axon-specific
knockdown of Lis1 or p150Glued prevented only induced
changes of transport. Why is induced but not constitutively
active transport dependent on local translation? A possible
explanation might be that in response to stimulation, previously
inactive dynein motor complexes get activated and coupled to
their cargos. We found that Lis1 synthesis in response to NGF
stimulation requires the association of Pafah1b1 with APC. As a
þTIP, APC is well situated to mediate the activation of dynein
through local production of regulatory proteins. In fact, the
Figure 7 | Association with APC separates axonally localized Lis1 transcripts into two functionally distinct pools. (a) Partial sequence of the 30-UTR of
rat Pafah1b1 starting at the stop codon (*). The binding regions of the CUGU and control LNAs are indicated in maroon and grey, respectively. The
CUGU element is underlined. (b) Dissociated DRG were transfected with control and CUGU LNA, and 24h later, APC RNA immunoprecipitation was
performed. Pafah1b1 was quantified by RT–PCR. 2DDCTvalues are reported relative to Tubb3 (positive control, binds APC but is not targeted by the LNAs).
Gfp was included as a control (no reads detected). Means±s.e.m. (n¼ 2 biological replicates with two technical replicates each). *Pr0.05. t-test. (c) DRG
neurons were cultured in microfluidic chambers. On DIV 3, the NGF concentration in the axonal chamber was changed to 5 ngml 1, and cell bodies were
selectively transfected with the control or CUGU LNAs. Twenty-four hours after transfection, axons were treated with 0, 5 or 100ngml 1 NGF for 12 h, and
axonal Pafah1b1 mRNA levels were determined by FISH. Background fluorescence was determined using a Gfp probe and subtracted. Means±s.e.m. of 15
optical fields per condition (n¼ 3 biological replicates). *Pr0.05. Two-way ANOVA with Fisher’s least significant difference test. Scale bar, 5mm. (d) DRG
neurons were cultured and transfected as in a. Twenty-four hours after transfection, axons were treated with 0, 5 or 100ngml 1 NGF for 10min, and
axonal Lis1 protein levels were measured by quantitative immunofluorescence. Means±s.e.m. of 20–30 optical fields per conditions (n¼4–6 biological
replicates). *Pr0.05. Two-way ANOVA with Fisher’s LSD test. (e–g) DRG neurons were cultured and transfected as in a. Twenty-four hours after
transfection, transport of LysoTracker-positive particles was observed in axons at baseline NGF (e), without NGF (f) or stimulated with NGF (g). Live-
imaging time-lapse series of axonal fields were acquired, with images being taken every 13 s for 4min. LysoTracker-positive particles with diametersZ1mm
were scored as anterograde, retrograde, bidirectional or stationary. Means±s.e.m. of nine optical fields per conditions (n¼ 3 biological replicates).
**Pr0.01. One-way ANOVA with Bonferroni’s multiple comparisons test. NS, not significant.
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recruitment of dynactin by þTIPs has been found to be required
for the initiation of retrograde axonal transport of various
cargos56. In Aspergillus nidulans, the Lis1 homolog has also been
described as an initiation factor for dynein-mediated transport
that is absent from and is unnecessary for dynein–cargo
complexes once they are in motion8. Local synthesis of Lis1 or
p150Glued at very precise loci in axons or growth cones could,
therefore, be a tuning or initiation mechanism for dynein-based
transport.
In essentially all instances, intra-axonal protein synthesis has
been seen to be stimulus-dependent. Our finding that NGF
deprivation triggers axonal Lis1 synthesis within 10min leads to
the question as to how withdrawal of a ligand can be a stimulus
for translation. The extremely short time needed to induce
translation rules out that it might be a consequence of neuronal
degeneration caused by the lack of trophic support. Rather,
translation appears to be triggered by a signalling pathway that is
active in the absence of NGF and suppressed by NGF-TrkA
binding. For example, TrkA has been proposed to act as a
dependence receptor that triggers cell death in the absence of its
ligand57. Our study provides additional support for the
dependence receptor hypothesis and, further, an experimental
paradigm in which to dissect the underlying cell intrinsic death
pathway downstream of TrkA.
Our finding that association with APC establishes distinct
pools of axonally localized Pafah1b1 mRNA that differ as to
whether they are translated in response to NGF stimulation or
withdrawal provides mechanistic insight into the differential
regulation of axonally localized mRNAs. APC localizes mRNAs to
microtubule plus-ends, and spatially orchestrates protein synth-
esis in axons and growth cones48. It remains unknown how many
of these translational hubs exist in axons. The finding that the
netrin receptor DCC binds components of the protein synthesis
machinery and regulates local translation58 suggests that APC is
not unique. In the fungus Ustilago maydis, polysomes are actively
transported on the surface of early endosomes and likely
translationally active there59. If the same occurs in neurons, it
would suggest that cargos might be able to hitch a ride on dynein
by locally synthesizing adaptor proteins on their surface.
In conclusion, through these studies, we provide a mechanistic
explanation for how a unidirectional motor can be tuned to fulfil
changing transport needs far away from the cell soma, and we
further reveal that transcripts of the same gene exist in axons in
functionally distinct pools based on their association with
translational hubs.
Methods
Compartmentalized DRG culture. All reagents were from ThermoFisher
Scientific (Waltham, MA) unless otherwise noted. To apply NGF, inhibitors or
siRNAs specifically to distal axons and growth cones without affecting the cell
bodies, DRG neurons were prepared from Sprague-Dawley embryonic day 15 rat
embryos of both sexes. All work involving animals was performed in accordance
with the National Institutes of Health guidelines for the care and use of laboratory
animals, and was approved by the Institutional Animal Care and Use Committee of
Columbia University. Embryonic rat DRGs were grown in tripartite microfluidic
chambers composed of three compartments (width of middle compartment:
500mm; side compartments: 1,500 mm) connected by two microgroove barriers
(microgroove length: 500 mm, width: 10mm, height: 3 mm)17,27. Microfluidic
chambers were produced according to published protocols18,60. The microfluidic
chambers were coated with 100mgml 1 poly-L-lysine (Trevigen, Gaithersburg,
MD). The plating medium (Neurobasal, 1 B27, 2mM glutamate, 20mM
50-fluorodeoxyuridine, 100 ngml 1 NGF) was completely exchanged for
5 ngml 1 NGF in both axonal compartments after 48 h. siRNA transfection in the
axonal compartments or LNA transfection in the somatic compartment
was performed on DIV 3, and all experiments were performed on DIV 4.
Whenever stated, the axonal compartments only were treated with anisomycin
(1mM, Sigma-Aldrich), emetine (2mM, EMD Millipore), rapamycin (10 nM,
Sigma-Aldrich), CEP-1347 (0.5 mM, Sigma-Aldrich), SB239063 (1 mM,
Sigma-Aldrich), lithium chloride (15mM) or SB216763 (10 mM, Sigma-Aldrich).
Live imaging of axonal cargos. Axonal transport of various cargos was visualized
using an Axio Observer.Z1 inverted microscope equipped with an AxioCam MRm
Rev. 3 camera (Zeiss, Thornwood, NY). To assay the effects of acute changes in
NGF signalling on axonal trafficking, 50 nM LysoTracker Green DND-26 was
added to axons when the axonal medium was changed to the experimental NGF
concentrations (0, 5 or 100 ngml 1), 15min before the start of imaging. For
imaging transport of NGF-containing endosomes, QD-NGF was prepared by
mixing mouse NGF 2.5S-Biotin (Alomone Labs, Jerusalem) and Qdot 585
Streptavidin Conjugate in a 1:1.2 molar ratio, and incubating them together at 4 C
with continuous inversion for 24 h. QD-NGF was diluted to 100 ngml 1 and
added to axons with a medium change 15min before imaging. During imaging,
neurons were kept in a CO2- and humidity-controlled incubation chamber
maintained at 37 C. Images were acquired every 13 s over a total 4-min time
period, with three fields of axons imaged per replicate. For motility analysis,
LysoTracker-positive particles were scored only if they were Z1 mm in diameter,
thereby allowing the identification and tracing of individual particles, whereas the
much scarcer and smaller QD-NGF particles were included only if they were
r0.5 mm in diameter. Particles were scored as stationary, anterograde, retrograde
or bidirectional according the following definitions: stationary if they travelled a
distance o1 mm during the observation period; anterograde or retrograde if they
displaced 43 mm in one direction; and bidirectional if they travelled 43 mm in
both directions.
Puromycylation assay. To visualized locally synthesized proteins, puromycin
(1.8 mM) was added to axons or cell bodies for 10min. Incorporation of
puromycin into nascent polypeptide chains was determined by quantitative
immunofluorescence and quantified as the numbers of puromycin-positive puncta
in axons or relative intensity of the puromycin immunofluorescence signal.
Fluorescence in situ hybridization. Antisense riboprobes were transcribed in vitro
from sense oligonucleotides containing a T7 promoter site (50-GCCCTATAGTG
AGTCGTATTAC-30) at their 30-end using the MEGAshortscript T7 Transcription
kit and digoxigenin-conjugated UTP (Roche, Indianapolis, IN). A mix of five
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FISH was performed as described previously17. Neurons grown in microfluidic
chambers were fixed in 4% paraformaldehyde in PBS for 20min at room
temperature. Following three washes with PBS, the cells were permeabilized with
0.5% Triton X-100 in PBS and washed twice more with PBS. The coverslips were
incubated with a total of 100 ng digoxigenin-labelled riboprobes (20 ng each of five
distinct riboprobes) in 30ml hybridization buffer (50% formamide, 2 SSC, 0.2%
bovine serum albumin (BSA), 1mgml 1 E. coli transfer RNA and 1mgml 1
salmon sperm DNA) overnight at 37 C. The coverslips were washed with constant
agitation at 37 C, first with 50% formamide in 2 SSC for 30min followed by
50% formamide in 1 SSC for another 30min. An additional three washes were
done at room temperature with 1 SSC for 15min each. The coverslips were
washed three times with PBS containing 0.1% Tween-20 for 5min each, blocked
with 3% BSA in PBST for 30min, and incubated with anti-digoxin (Sigma-Aldrich,
DI-22; 1:500) and anti-b-III tubulin (Abcam, ab41489; 1:1,000) antibodies in
blocking solution overnight at 4 C. The coverslips were washed three times with
PBST and incubated with fluorophore-conjugated Alexa secondary antibodies
(1:2,000) for 1 h at room temperature, and washed and mounted with ProLong
Gold antifade reagent. b-III tubulin staining was used to generate a mask within
which the intensity of the FISH signal was quantified. Average fluorescence
intensity of axonal fields that were incubated with a Gfp probe was subtracted from
the fluorescence intensities resulting from hybridization with Pafah1b1 or Dctn1
riboprobes.
Quantitative immunofluorescence imaging. Axons of neurons grown in
microfluidic chambers were exposed to 0, 5 or 100 ngml 1 NGF for 10min, either
in the presence of protein synthesis inhibitors or after pretreatment with siRNAs.
Neurons were fixed with 4% paraformaldehyde/4% sucrose in PBS for 20min at
room temperature. The coverslips were washed three times in PBS, blocked for 1 h
with BGT buffer (3% BSA, 0.25% Triton X-100 and 100mM glycine) and
incubated with primary antibodies against b-III tubulin (Abcam, ab7751; 1:500),
4EBP1, p-4EBP1 (Cell Signaling Technology, 1:1,000), puromycin (Millipore,
MABE343; 1:250), Lis1 (Sigma-Aldrich, SAB3500302, 1:400) or p150Glued (Abcam,
ab11806, 1:500). Images of distal axons or growth cones were acquired in Z-stacks
using a Plan-Apochromat  63/1.40 oil objective.
siRNA and LNA transfection. Axon-specific silencing of Pafah1b1 and Dctn1
mRNAs was achieved by transfecting siRNAs into axons concomitant with the
axonal medium change on DIV 3 using NeuroPORTER (Genlantis, San Diego, CA)
as the transfection reagent. The following siRNAs were used to target rat Pafah1b1
(NM_031763.3): 50-CCUUUGACCACAGUGGCAAACUCUU-30 and 50-GGA
UUUCCAUAAGACGGCACCCUAU-30; and Dctn1 (NM_024130.1): 50-GAGCGC
UCCUUAGAUUUCCUCAUCG-30 and 50-GACAUCCGUCAGUUCUGCAAGA
AGA-30. Negative control siRNA was purchased from ThermoFisher Scientific
(Stealth RNAi siRNA Negative Control Med GC Duplex #3).
LNAs were transfected into the cell body compartment on DIV 3 using
NeuroPORTER. The following high-performance liquid chromatography-purified
LNAs (Exiqon, Woburn, MA) were used to target bases 1,878–1,891 (control LNA)
or 1,905–1,921 (targeting the CUGU motif APC-binding site) of rat Pafah1b1
mRNA: 50-CAþTGAAþTACTTþTGT-30 and 50-AþTTTAþCAGTA
þTACAAþTT-30 , respectively; preposedþ signifies LNA base.
Immunoblot. The efficacy of each siRNA employed was validated by western
blotting of endogenous protein from rat C6 glioma cells transfected at 50–80%
confluence and cultured for 72 h to allow time for effective knockdown. Cells were
lysed in RIPA buffer and proteins were resolved by 4–12% SDS–polyacrylamide gel
electrophoresis on NuPAGE Bis-Tris gels, electrotransferred to Immobilon-P
PVDF membranes (Millipore), blocked with 5% (w/v) nonfat milk, probed with
primary antibodies followed by incubation with horseradish peroxidase-conjugated
secondary antibodies (Pierce) and visualized with SuperSignal West Pico
Chemiluminescent substrate (Pierce). Protein quantification was performed using
ImageJ (NIH) software. The primary antibodies used for loading controls were:
b-actin (1:10,000, Millipore) and cofilin (1:1,000, Cell Signaling Technology).
horseradish peroxidase-conjugated secondary antibodies were used at 1:2,000.
Images have been cropped for presentation. Full-size images are presented in
Supplementary Fig. 4.
TUNEL and calcein AM staining. TUNEL was performed on fixed samples using
the DeadEnd Fluorometric TUNEL System (Promega, Madison, WI), and nuclei
were counterstained with 4,6-diamidino-2-phenylindole. Survival was analysed
using calcein staining in living cells. Cell bodies were incubated with 4.17 mgml 1
calcein AM dye in dimethylsulphoxide for 40–60min at 37 C. Calcein was
quenched with 15mgml 1 bovine haemoglobin (Sigma-Aldrich), and nuclei
were labelled with Hoechst stain. Cells were live imaged inside the microscope
incubation chamber kept at 37 C and 5% CO2. TUNEL-positive nuclei and
calcein-positive cells were scored in five fields per replicate that were proximal to
the microgrooves.
Real-time RT–PCR. RNA was purified from the axonal compartments of
microfluidic chambers using the PrepEase RNA Isolation kit (Affymetrix, Santa
Clara, CA) and concentrated using the RNeasy MinElute Cleanup kit (Qiagen,
Valencia, CA). A total amount ofB2 ng was generally isolated from axonal lysates,
which was concentrated into 10 ml for reverse transcription. Reverse transcription
was performed using SuperScript III First-Strand Synthesis SuperMix for
qRT–PCR. Real-time RT–PCR was performed with TaqMan Gene Expression
master mix in a StepOnePlus Real-Time PCR instrument using the following
conditions: an initial denaturation step at 95 C for 10min, followed by 40 cycles of
denaturation at 95 C for 15 s and extension at 60 C for 1min. Pafah1b1 and
Dctn1 levels were normalized to Gapdh.
RNA immunoprecipitation. CUGU and control LNAs were transfected into
dissociated DRGs and 24 h later the DRGs were lysed in RIP buffer (150mM KCl,
25mM Tris-HCl, 5mM EDTA, 0.5mM dithiothreitol, 0.5% NP40,þ protease
inhibitors). The cleared lysate was incubated with an APC antibody (Santa Cruz
Biotechnology, sc-896; 1:500) overnight at 4 C. Antibody–protein–RNA
complexes were precipitate by incubation under agitation with Dynabeads for 1 h
at 4 C. The beads were washed five times in ice-cold RIP buffer. RNAzol RT was
added to the beads, RNA was purified using the Direct-zol RNA MicroPrep kit
(Zymo Research) with DNaseI treatment. Complementary was synthesized using
the iScript Reverse Transcript Supermix for RT–qPCR. RT–PCR was run according
to the guidelines for TaqMan Fast Advance Master Mix.
Statistical analyses. All experiments were performed in at least three biological
replicates to gain sufficient power for meaningful statically analyses. Two means
were compared by t-tests, whereas multiple means were compared using one-way
ANOVAs with multiple comparisons testing. When comparing multiple groups in
experiments with more than one variable, two-way ANOVA was performed. For all
comparisons, normal distribution and variance were determined and appropriate
statistical tests chosen.
Data availability. Data supporting the findings of this study are available within
the article (and its Supplementary Information files) and from the corresponding
author on reasonable request.
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Localized protein synthesis is a mechanism for
developing axons to react acutely and in a spatially
restricted manner to extracellular signals. As such,
it is important for many aspects of axonal develop-
ment, but its role in the formation of presynapses re-
mains poorly understood. We found that the induced
assembly of presynaptic terminals required local
protein synthesis. Newly synthesized proteins were
detectable at nascent presynapses within 15 min of
inducing synapse formation in isolated axons. The
transcript for the t-SNARE protein SNAP25, which
is required for the fusion of synaptic vesicles with
the plasma membrane, was recruited to presynaptic
sites and locally translated. Inhibition of intra-axonal
SNAP25 synthesis affected the clustering of SNAP25
and other presynaptic proteins and interfered with
the release of synaptic vesicles from presynaptic
sites. This study reveals a critical role for the axonal
synthesis of SNAP25 in the assembly of presynaptic
terminals.
INTRODUCTION
During thedevelopment of thenervoussystem, axonsproject over
long distances to their cognate targets, until upon contact with
target-derived adhesive or soluble factors the assembly of a pre-
synaptic terminal is initiated (Chia et al., 2013; Jin and Garner,
2008). Application of these presynaptic organizing molecules to
isolated axons is sufficient to induce presynapse formation from
components that have been transported from the neuronal
soma. An alternative source for at least some of the presynaptic
proteinsmightbe theaxon itself through theprocessof local trans-
lation. Protein synthesis in axons is required for proper axondevel-
opment (Campbell and Holt, 2001; Gracias et al., 2014; Hengst
et al., 2009;Wuet al., 2005) byproviding a spatially and temporally
tightly restricted source of protein in response to extracellular sig-
nals (Batista and Hengst, 2016). Transcripts coding for several
presynapticproteinshavebeen found indevelopingcortical axons
(Tayloretal., 2009), and, inAplysia, protein synthesis is required for
the formation of presynapses (Schacher andWu, 2002). Recently,
the importance of presynaptic protein synthesis in the control of
neurotransmitter release was reported for the mature mammalian
brain (Younts et al., 2016), but the role of local translation in the
formation of presynapses remains poorly understood. Specif-
ically, it is unknown whether axonal protein synthesis is required
for the assembly of presynaptic terminals. So far, only one locally
synthesized protein has been described that accumulates at
nascent presynapses, b-catenin, where it regulates the release
of synaptic vesicles (Taylor et al., 2013). Here, we report the
induced intra-axonal synthesis of the t-SNARE protein synapto-
somal-associated protein 25 (SNAP25) as a necessary, early
step for the clustering of presynaptic proteins and the formation
and function of presynapses.
RESULTS
Presynaptic Proteins Cluster within 1 hr at Contact Sites
with PDL-Coated Beads
To investigate whether the formation of presynapses requires
local protein synthesis, we cultured embryonic hippocampal
neurons in tripartite microfluidic chambers that allow the fluidic
isolation of axons from cell bodies and dendrites (Figure 1A)
(Baleriola et al., 2014; Taylor et al., 2005). Poly-D-lysine (PDL)-
coated latex beads were applied selectively to the axonal com-
partments to induce the clustering of presynaptic proteins (Lu-
cido et al., 2009; Taylor et al., 2013). Immunostaining revealed
significantly increased levels of several presynaptic proteins
(b-catenin, synaptophysin, GAP-43, SNAP25) and tau at contact
sites between axons and PDL-coated beads after 24 hr of incu-
bation, while b-III tubulin levels were unchanged (Figure 1B). As
local protein synthesis is frequently an acute reaction to an
external stimulus, we next investigated how early after addition
of the PDL-coated beads we could detect clustering of presyn-
aptic proteins. SNAP25 levels were significantly increased after
1 hr of contact with the PDL-coated beads (Figure 1C).
Inhibition of Axonal Protein Synthesis Prevents
Clustering of b-Catenin and SNAP25 at 1 hr
Previously, it has been reported that the clustering of b-catenin at
3 hr after addition of PDL-coated beads requires local protein
synthesis (Taylor et al., 2013). To determine whether the clus-
tering of other presynaptic proteins is likewise dependent on
Cell Reports 20, 3085–3098, September 26, 2017 ª 2017 The Author(s). 3085




Figure 1. Clustering of Presynaptic Markers at PDL-Coated Beads in Axons
(A) Scheme of a tripartite microfluidic chamber used to selectively treat axons. Embryonic hippocampal neurons were seeded in the upper compartment of the
chamber (teal) and axons cross through two microgroove barriers (500-mm-long) into the middle and lower axonal compartments (yellow). After DIV10, PDL-
coated or uncoated beads were added to the axonal compartments for 15min to 1 hr, and clustering of presynaptic proteins (i.e., b-catenin, SNAP25) adjacent to
the bead-axon contact sites was determined by immunofluorescence (IF).
(B) Axonswere incubatedwith PDL-coated beads for 24 hr and immunostained for presynaptic and axonal proteins. Levels of b-catenin, synaptophysin, SNAP25,
GAP43, and tau are significantly increased at axon-bead contact sites. IF and IF merged with differential interference contrast (DIC) images are shown; yellow
dashed circles outline beads. Quantifications are relative to off-bead fluorescence values. Mean ± SEM of 30–120 axonal fields (n = 3 biological replicates per
condition). Unpaired t tests. n.s., not significant; **p < 0.01; ****p < 0.0001.
(legend continued on next page)
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axonal translation, we focused on SNAP25 and added the
protein synthesis inhibitor emetine selectively to the axonal
compartment during the treatment with uncoated or PDL-coated
beads (Figure 2A). We quantified the fluorescent intensity within
axons along a 30-mm-long line starting at the center of the beads
(Figure 2B). Within 1 hr of treatment with PDL-coated beads,
b-catenin and SNAP25 were significantly increased in the first
5 mm from the beads’ centers, i.e., at contact sites (Figures
2C–2E). The clustering of b-catenin and SNAP25 did not show
any bias for either the proximal (i.e., toward the cell body) or
distal side of the beads (Figure S1); thus, for our analyses we
did not distinguish between the proximal and distal sides. Un-
coated beads did not induce clustering, and addition of emetine
completely prevented the clustering of b-catenin and SNAP25.
Neither tau nor b-III tubulin clustered at this early time point (Fig-
ures 2F and 2G). To determine whether the observed protein
synthesis dependency of b-catenin and SNAP25 clustering at
1 hr was limited to this early time point, we analyzed their clus-
tering at 3, 6, and 12 hr after addition of beads and emetine to
the axons. While SNAP25 clustering required protein synthesis
at all time points tested, b-catenin clustering was significantly
affected by emetine only at 3 hr (as previously reported by Taylor
et al., 2013, but not at the later time points [Figure 2H]).
PDL-Coated Beads Induce Protein Synthesis at Axonal
Contact Sites within 15 min
The requirement for local translation for clustering after 1 hr of in-
cubation with PDL-coated beads indicated that this treatment
might trigger protein synthesis directly andacutely at contact sites
withaxons.Weusedpuromycylation, alsoknownasSUnSET (Fig-
ure 3A) (Schmidt et al., 2009), to detect protein synthesis events in
axons. Puromycin is a tRNA analog that gets incorporated into the
nascent protein chain (Yarmolinsky and Haba, 1959), allowing the
detection of protein synthesis in situ with an anti-puromycin
antibody. We detected a significant increase in the number of
puromycin-positive puncta in axons at contact sites within
15min of addition of PDL-coated beads (Figure 3B). The increase
of the puromycin signal was accompanied by an increased pres-
ence of phospho-4EBP1, a marker for active translation, at con-
tact sites with PDL-coated but not uncoated beads (Figure 3C).
To investigate whether the immediate induction of protein synthe-
sis was sustained over a longer time period, we added the beads
for 1 hr and shifted the puromycylation time window to the last
10min of the assay. As before, the addition of PDL-coated beads
was associated with a significantly higher number of puromycyla-
tion-positive puncta in their immediate vicinity compared to
uncoated beads, and addition of the protein synthesis inhibitor
anisomycin completely abolished this effect (Figure 3D).
Detection of SNAP25 mRNA in Axons by Fluorescent In
Situ Hybridization
mRNA encoding SNAP25 has previously been found in axons of
cortical neurons (Taylor et al., 2009), but it was below the detec-
tion threshold in other axonal transcriptome datasets (Baleriola
et al., 2014; Zivraj et al., 2010). Here, we used single-molecule
inexpensive fluorescent in situ hybridization (smiFISH; Tsanov
et al., 2016) to directly visualize SNAP25 transcripts in axons of
dissociated embryonic hippocampal neurons and to determine
whether their intra-axonal localization changes in response to
treatment with PDL-coated beads (Figure 4A). SNAP25 mRNA
FISH-positive puncta were readily detectable at contact sites
with PDL-coated beads, indicating that contact with PDL-coated
beads recruits SNAP25 transcripts. The axonal smiFISH signal
for SNAP25 mRNA was specific as transfection of axons with a
SNAP25 small interfering RNA (siRNA) greatly reduced the num-
ber of positive puncta (Figure 4B).
SNAP25 Is Synthesized Locally at Contact Sites of Axons
with PDL-Coated Beads
The protein synthesis-dependent clustering of SNAP25 and the
presence of its mRNA in axons at contact sites with PDL-coated
beads indicated that SNAP25 itself might be locally produced.
To test this hypothesis, we adopted a different design of micro-
fluidic chambers (Figure 4C) (Park et al., 2009). In these circular
chambers, axons grow into the central open compartment, al-
lowing the collection of axonal material in quantities required
for biochemistry. SNAP25 protein was detectable by immuno-
blot in lysates of axons treated with uncoated beads. Application
of PDL-coated beads for 24 hr greatly increased the presence of
SNAP25 in axons and treatment of axons with emetine reduced
SNAP25 below detection limit without affecting SNAP25 expres-
sion in the cell body compartment (Figure 4C). To directly visu-
alize SNAP25 synthesis at contact sites with PDL-coated beads,
we combined puromycylation with a proximity ligation assay
(puro-PLA) (Figure 4D) (tom Dieck et al., 2015). Axons that
were not treated with PDL-coated beads showed very few
SNAP25 puro-PLA puncta, while treatment with PDL-coated
beads induced the local synthesis of SNAP25 (Figure 4E). As
before, we tested how persistent the induction of SNAP25 syn-
thesis was by incubating the axons for 1 hr with PDL-coated
beads and adding puromycin for the last 10 min. SNAP25
puro-PLA puncta were readily detectable, and their presence
was abolished by the presence of the protein synthesis inhibitor
anisomycin (Figure 4F). Together, these results establish that
SNAP25 is locally synthesized upon contact of axons with
PDL-coated beads.
SNAP25 Is Locally Synthesized at Synapses
So far, our approach has been to induce formation of presynap-
ses by applying PDL-coated beads. This approach allows us to
study presynaptic events required for the clustering of presynap-
tic proteins in the absence of a postsynaptic cell, but it is neces-
sarily artificial. To test whether SNAP25 is locally synthesized at
synapses rather than at induced presynaptic specializations, we
cultured embryonic hippocampal neurons in regular dissociated
cultures and performed SNAP25 puro-PLA assays on DIV5, 10,
(C) Axons were incubated with PDL-coated and uncoated beads for the indicated times and immunostained for SNAP25. SNAP25 immunoreactivity is sig-
nificantly increased at contact sites with PDL-coated beads at all time points. Fluorescence is normalized to off-bead values. Mean ± SEM of 30–50 axonal fields
(n = 3–4 different biological replicates per condition). Two-way ANOVA with Bonferroni’s multiple comparison test. *p < 0.05; **p < 0.01.
Scale bars, 5 mm.
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Figure 2. Clustering of b-Catenin and SNAP25 at PDL-Coated Beads Requires Local Protein Synthesis
(A) Experimental design: on DIV11 axons were treated with PDL-coated or uncoated beads in the presence of a protein synthesis inhibitor (emetine, 100 nM) or
vehicle. Cultures were fixed at different time points after treatment.
(legend continued on next page)
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and 15 (Figure 4G). SNAP25 puro-PLA puncta were visible in
axons and dendrites at all developmental stages, and their fre-
quency increased with the age of the cultures (Figure 4G). In
DIV15 cultures, some SNAP25 puro-PLA puncta were found jux-
tapositioned to the postsynaptic protein PSD-95, indicating
SNAP25 synthesis at established synapses. The appearance of
SNAP25 puro-PLA puncta was prevented at all developmental
stages if the cells were incubatedwith vehicle instead of puromy-
cin or if the protein synthesis inhibitor anisomycin was added
during the puromycylation (Figure 4H).
Axon-Specific Knockdown of SNAP25 mRNA Reduces
SNAP25 Synthesis at Contact Sites with PDL-Coated
Beads
To investigate the requirement of localized SNAP25 or b-catenin
mRNAs, we selectively transfected the axons of hippocampal
neurons grown in microfluidic chambers with siRNA (Figure 5A).
Previously,we have found that RNAi is functional in axons (Hengst
et al., 2006) and that localizedmRNAs can be selectively knocked
down using locally applied siRNAs without affecting protein
expression in dendrites or cell bodies (Baleriola et al., 2014; Gra-
cias et al., 2014; Hengst et al., 2009; Villarin et al., 2016). When
we transfected axons with a SNAP25 siRNA, the effect was
restricted to axons (Figure 5B). The knockdown of SNAP25
mRNA in axons was only partial, likely because of the tight pack-
aging of axonal mRNAs in granules (Buxbaum et al., 2014), which
makes them inaccessible for the RNAi machinery while silenced
but susceptible to siRNAunder conditions that activate their trans-
lation, as we have observed previously (Baleriola et al., 2014; Vil-
larin et al., 2016).Knockdownof axonal SNAP25 transcripts signif-
icantly reduced the appearance of SNAP25 puro-PLA puncta at
contact sites with PDL-coated beads and increased that percent-
age of beads that had no puncta in their vicinity (Figure 5C).
Together, these results establish that axonal transfection of
SNAP25 siRNA is an efficient method to prevent the local transla-
tion of SNAP25 at contact sites with PDL-coated beads.
Clustering of SNAP25 and b-Catenin Requires the
Presence of Their Transcripts in Axons
Next, we used this approach to investigate whether the local
translation of SNAP25 or b-catenin was required for the clus-
tering of these proteins. As before, we selectively knock down
SNAP25 or b-catenin transcripts in axons by locally applied
siRNA and measured protein clustering 1 hr after the applica-
tion of PDL-coated beads (Figure 5D). Knockdown of axonal
SNAP25 mRNA significantly prevented the clustering of
SNAP25 at contact sites with PDL-coated beads (Figure 5E).
Knockdown of b-catenin mRNA did not prevent clustering of
b-catenin directly at the contact sites (0–5 mm) but led to broad-
ening of the peak with increased b-catenin levels at 5–10 mm
(Figure 5F). This result indicates that the vast majority of b-cate-
nin protein clustering at PDL-coated beads is not derived from
acutely triggered local synthesis but rather is of somatic origin.
However, a small amount of b-catenin whose local synthesis is
prevented by the siRNA appears to be required to induce the
clustering of b-catenin directly at contact sites. The b-catenin
siRNA used here efficiently knocks down its target mRNA
when applied to dissociated hippocampal neurons (Figure 5G).
Together, these results suggest that most of the SNAP25
required during the early stages of presynapse formation is
derived from local protein synthesis.
Clustering of SNAP25 and b-Catenin Requires Each
Other’s Local Synthesis
Next, we used the same experimental approach to test the recip-
rocal requirement of SNAP25 and b-catenin synthesis for the
clustering of these proteins. Clustering of b-catenin protein
was significantly reduced in axons depleted of SNAP25 mRNA
(Figure 6A). In axons with b-catenin mRNA knockdown, clus-
tering of SNAP25 protein was reduced as well, and the peak
for SNAP25 was broadened as we had seen before for b-catenin
protein itself (Figure 6B).
Knockdown of Axonal SNAP25 mRNA Interferes with
Vesicle Release from Induced Presynaptic Sites
Last, we performed functional assays on induced presynaptic
sites in axons transfected with siRNA similar to a previously
described approach (Taylor et al., 2013). To study the release
of synaptic vesicles at induced presynaptic sites, we used
FM4-64. FM dyes are lipophilic dyes that can be endocytosed
and incorporated into synaptic vesicles. We stimulated cells
with a high potassium solution in the presence of FM4-64 and
let dye endocytosis occur. Cells were then imaged and stimu-
lated a second time with high potassium. As vesicles are exocy-
tosed, dye molecules are released and rapidly diffuse, resulting
in nerve terminal destaining. In axons transfected with the siRNA
targeting SNAP25, release of synaptic vesicles as measured by
the disappearance of fluorescence was significantly slower than
in scrambled siRNA-transfected axons, while the loading was
not different (Figures 7A and 7B). Again, this effect was limited
to the siRNA-treated axons, as the unloading dynamic was un-
changed at synapses in the cell body compartment (Figure 7C).
As an additional control, we transfected axons with an siRNA tar-
geting another presynaptic protein, piccolo (Fenster et al., 2000),
whose transcript is absent from axonal transcriptome or transla-
tome datasets (Shigeoka et al., 2016; Taylor et al., 2009).
(B) A three-pixel-wide line was drawn along the axon, starting at the center of the bead. Fluorescence along this line was quantified for 30 mm and normalized
against the average fluorescence in last 15 mm. Beads have a diameter of 5 mm.
(C–G) Axon were immunostained for b-catenin (C and D), SNAP25 (C and E), tau (F), and b-III tubulin (G) after 1 hr of treatment. b-catenin and SNAP25 increased in
the direct vicinity of the beads in a protein synthesis inhibitor sensitive manner, while tau and b-III tubulin levels remained unchanged. IF and IF merged with DIC
images are shown; yellow dashed circles outline beads. Fluorescence intensities obtained in the lines scans were averaged and normalized. The area under the
curve (AUC) was then calculated for the first 5 mm and 5–15 mm from the bead center. Mean ± SEM of 30–120 beads (n = 3 biological replicates per condition).
(H) Axons were immunostained for b-catenin or SNAP25 after 3, 6, or 24 hr of treatment. SNAP25 levels were significantly increased at bead contact sites at all
times tested. The effect for b-catenin was significant only at 3 hr, and emetine did not affect b-catenin levels at 24 hr.
One-way ANOVA with Tukey’s multiple comparison tests and unpaired t tests. n.s., not significant; *p < 0.05; **p < 0.01; ***p < 0.001. Scale bars, 5 mm. See also
Figure S1.
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Figure 3. PDL-Coated Beads Induce Axonal Protein Synthesis
(A) Puromycylation assay: ribosomes incorporate puromycin into nascent polypeptide chains, leading to elongation termination and premature chain release. An
antibody against puromycin is used to label nascent proteins in situ.
(B) Axons were treated with PDL-coated beads and puromycin or puromycin alone for 15 min and immunostained for puromycin and b-III tubulin. The level of
puromycylation, indicating de novo protein synthesis is significantly increased at contact sites with PDL-coated beads. Mean ± SEM of 30 axonal fields per
condition (n = 3 biological replicates). Unpaired t test. *p < 0.05.
(C) Axons were treated with uncoated or PDL-coated beads and puromycin for 15 min and immunostained for phospho-4EBP1, b-III tubulin, and puromycin. The
signal for p-4EBP1, indicating activation of translation, co-localizes with the puromycin signal at contact sites with PDL-coated beads.
(D) Uncoated beads, PDL-coated beads, or PDL-coated beads and the protein synthesis inhibitor anisomycin (10 mM) were added to the axonal compartments.
Puromycin was added to axons during the last 10min of the assay. The number of puromycin-positive puncta in a circle of 5 mmaround each bead center and the
percentage of all beads imaged in each condition with no puncta or at least one puncta in the 5-mm circle were plotted. Means ± SEM of 40–142 beads in 30
axonal fields (n = 3 different biological replicates). One-way ANOVA with Tukey’s multiple comparison test. *p < 0.05; ***p < 0.001.
Yellow dashed line represents bead location. Scale bars, 5 mm.
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Neuron-wide knockdown of piccolo causes enhanced synaptic
vesicles exocytosis rates (Leal-Ortiz et al., 2008), but axon-spe-
cific delivery of piccolo siRNA had no effect on synaptic vesicle
release, again demonstrating that the siRNAs act only locally in
axons and do not interfere with protein expression and transport
from the cell body (Figure 7D).
DISCUSSION
Our results establish that SNAP25 synthesis is locally activated
by a presynaptic organizing signal and required for presynaptic
terminal assembly. Previously, it has been reported that b-cate-
nin is locally synthesized at nascent presynaptic sites and that
the locally produced protein regulates the release dynamics of
synaptic vesicles (Taylor et al., 2013). The question of whether
local protein synthesis was required for the assembly of presyn-
aptic terminal was not directly addressed. Here, we demonstrate
that localized protein synthesis is a required step in the formation
of presynaptic sites.
In accordance with Taylor et al. (2013), we also detect that
b-catenin is locally synthesized. We find, however, differences
in the requirement for local SNAP25 and b-catenin synthesis.
While inhibition of protein synthesis prevents the accumulation
of SNAP25 protein at contact sites with PDL-coated beads at
all time points tested (1–12 hr), the accumulation of b-catenin is
only affected until the 3-hr time point, indicating that at this time
anterograde transport sufficiently meets the demand for b-cate-
nin at presynapses. This difference is not easily explained by dif-
ferences in the stability of SNAP25 and b-catenin: the half-life of
SNAP25 during synaptogenesis in cerebellar granule neurons
was reported to be 16 hr (Sanders et al., 1998), slightly longer
than the half-life of b-catenin in PC12 cells of 12 hr (Bareiss
et al., 2010). Instead, the role of the locally synthesized proteins
appears to differ. While axonal-specific siRNA treatment pre-
vents the clustering of SNAP25 directly at contact sites with
PDL-coated beads by around 50%, the analogous treatment
leads to a broadening of the profile for b-catenin: the amount of
protein found directly at beads is not significantly reduced but
instead more b-catenin accumulates in the vicinity of the beads
(5- to 15-mm distance from the bead center). These findings indi-
cate that 1 hr after contactwith the beads nearly half of presynap-
tic SNAP25 protein is derived from local synthesis. In contrast,
nearly all b-catenin accumulates at or near the beads indepen-
dently of local protein synthesis, i.e., by anterograde transport
from the cell body. The small amount of locally produced b-cate-
nin is required to cluster the anterogradely transported protein
directly at presynaptic sites. Thus, while local production of
b-catenin is required only during the first steps of presynapse as-
sembly and does not generate the bulk of presynaptic b-catenin
protein, SNAP25 synthesis persists at least until 12 hr after initia-
tionof presynapse formation, it generates a substantial amount of
synaptic SNAP25proteins, and it continues to be required even in
established synapses, as demonstrated by the effect of axonal
SNAP25 mRNA knockdown on synaptic vesicle release.
A recent translatome analysis of retinal ganglion cells axons
identified SNAP25 as highly expressed not only in developing,
but also in mature axons (Shigeoka et al., 2016), and inhibition
of protein synthesis at established presynaptic terminals dereg-
ulates GABA release (Younts et al., 2016). The stability of
SNAP25 at presynapses is controlled by activity induced ubiqui-
tination and proteasome-dependent degradation (Sheehan
et al., 2016). SNAP25 synthesis at established synapses might
therefore be an important mechanism for the control of synaptic
SNAP25 levels and synapse function.
mRNA localization to axons is generally understood to be
controlled by RNA-binding proteins that associated with mRNAs
Figure 4. SNAP25 Is Locally Synthesized in Axons
(A) After DIV11, PDL-coated beads were added to the axonal compartments, and 24 hr later cells were fixed and processed for Snap25 or Gfp smiFISH, and
Snap25 andGfp positive puncta at bead contact sites were counted. SNAP25 transcripts accumulated at bead contact sites. Mean ±SEM of ten axonal fields per
condition (n = 3 biological replicates). Unpaired t test. ****p < 0.0001. Scale bar, 5 mm.
(B) Hippocampal neurons were cultured inmicrofluidic chambers for 10 days. siRNAwas applied only to the axonal compartments for 24 hr, and the neuronswere
processed for Snap25 smiFISH. Axonal transfection with SNAP25 siRNA greatly reduced the number of SNAP25 puncta, establishing the specificity of the axonal
Snap25 smiFISH signal. Mean ± SEM of ten axonal fields per condition. Unpaired t tests. *p < 0.05. Scale bar, 5 mm.
(C) Scheme of a circular microfluidic chamber used for selective axonal treatments and protein isolation. Embryonic hippocampal neurons are seeded in the inner
compartment and axons cross through amicrogroove barrier (500-mm-long) into an open circular (6-mm-diameter) compartment. After DIV11, uncoated beads or
PDL-coated beads with or without emetine (100 nM) were added to the axonal compartment only, and 24 hr later proteins were obtained from both somatic and
axonal compartments and analyzed for immunoblot blot. Selective treatment of axons with PDL-coated beads resulted in an increase of SNAP25 protein only in
axons but not in cell bodies. This increase was blocked with local application of the protein synthesis inhibitor emetine.
(D) Principle of puro-PLA: puromycin is incorporated by active ribosomes into nascent polypeptide chains. A proximity ligation assay with antibodies against
puromycin and the protein of interest—here: SNAP25—is used to detect synthesis of this protein.
(E) Axons of hippocampal neurons cultured in microfluidic chambers for 11 days were treated with PDL-coated beads and puromycin or puromycin alone for
15 min and processed for puro-PLA against SNAP25. The number of SNAP25 puro-PLA puncta is significantly increased in axons incubated with PDL-coated
beads. Mean ± SEM of ten axonal fields per condition (n = 3 biological replicates). Unpaired t test. **p < 0.01.
(F) PDL-coated beads or PDL-coated beads and the protein synthesis inhibitor anisomycin (10 mM) were added to the axonal compartments for 1 hr. Puromycin
was added to axons during the last 10 min of the assay. The number of SNAP25 puro-PLA-positive puncta in a circle of 5 mm around each bead center and the
percentage of all beads imaged in each condition with no puncta or at least one puncta in the 5-mmcircle were plotted. Means ± SEM of 76–84 beads in five to ten
axonal fields per condition (n = 4 different biological replicates). Scale bars, 5 mm.
(G) Dissociated hippocampal neurons were cultured for 5, 10, or 15 days and incubated with puromycin for 10 min before fixation. Closed arrowheads indicate
puro-PLA puncta and opened arrowheads PSD-95 puncta. Scale bars, 10 mm.
(H) Dissociated hippocampal neurons were cultured for 5, 10, or 15 days and processed for SNAP25 puro-PLA without puromycin incubation or after incubation
with puromycin and anisomycin for 10 min before fixation. Closed arrowheads indicate puro-PLA puncta and opened arrowheads PSD-95 puncta. Scale bars,
10 mm.
See also Table S1.
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Figure 5. Effect of Local siRNA on b-Catenin and SNAP25 Clustering
(A) Experimental design for (C): hippocampal neurons were cultured inmicrofluidic chambers for 10 days. siRNAwas applied only to the axonal compartments for
24 hr before PDL-coated beads were added for 1 hr. Puromycin was added to the axons for the last 10 min before fixation and processing for SNAP25 puro-PLA.
(B) SNAP25mRNA levels were quantified by RT-PCR in lysates obtained from the axonal and the cell body compartment 48 hr after transfection of the axons with
siRNA. SNAP25 levels were reduced significantly reduced in axons but not in the cell bodies, demonstrating that the axonally applied siRNAs act exclusively
locally. Mean ± SEM (n = 3 biological replicates).
(legend continued on next page)
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through sequence elements nearly always found in the 30 UTRs
of the transcripts. Interestingly, several SNPs located in the
30 UTR of SNAP25 are linked to adult attention deficit disorder
(ADHD) (Barr et al., 2000; Brophy et al., 2002; Kustanovich
et al., 2003; Mill et al., 2004). In the context of our findings, it is
tempting to speculate that these mutations might interfere with
the local synthesis of SNAP25 at presynaptic sites. Future inves-
tigation of the potentially changes in subcellular localization and
synaptic translation of SNAP25 mRNA might provide a mecha-
nistic understanding of how these mutations are linked to hyper-
active disorders.
In conclusion, we describe an alternative source for presynap-
tic proteins, intra-axonal synthesis, that is required the formation
presynaptic terminals.
EXPERIMENTAL PROCEDURES
Compartmentalized Culture of Embryonic Hippocampal Neurons
All work involving animals was performed in accordance with NIH guide-
lines for the care and use of laboratory animals and was approved by the
Institutional Animal Use and Care Committee (IACUC) of Columbia Univer-
sity. All reagents were purchased from Thermo Fisher Scientific unless
otherwise noted. Hippocampal neurons were harvested from Sprague-
Dawley embryonic day 17/18 rat embryos (Kaech and Banker, 2006). Em-
bryonic rat neurons were grown in tripartite microfluidic chambers with
500-mm-long microgrooves connecting the three fluidically isolated com-
partments. Microfluidic chambers were produced according to published
protocols (Gracias et al., 2014; Park et al., 2006). Primary hippocampal
neurons (50,000–60,000 cells per chamber) were cultured in one of the
side compartments, and axons were allowed to grow into the other two
compartments. Chambers were coated with 0.1 mg mL–1 poly- D-lysine
(Sigma-Aldrich) and 2 mg mL–1 laminin (Trevigen). After 24 hr, plating me-
dium (neurobasal, 10% fetal bovine serum, 100 mM glutamine, 1mM so-
dium pyruvate, 100 IU mL–1 penicillin, 100 mg mL–1 streptomycin) was
completely exchanged for growth medium (neurobasal, 1 3 B27, 100 mM
glutamine). Half of this growth medium was replaced with fresh growth me-
dium on DIV4 and 8. All experiments were performed at DIV9–11. Whenever
stated, axonal compartments were treated with emetine (100 nM, EMD
Millipore) or anisomycin (10 mM, Sigma-Aldrich).
Presynaptic Clustering with PDL-Coated Beads
Bead preparation and treatments were performed as described (Lucido et al.,
2009; Taylor et al., 2013). Surfactant-free aliphatic amine latex microspheres
4–5 mm in diameter (Invitrogen) were coated in 50 mgmL–1 PDL (Sigma-Aldrich)
at 37C for at least 2 hr, rinsed twice with water, and diluted in growth medium.
Uncoated beads were incubated in water. Around 150,000 PDL-coated beads
were added to each axonal compartment through the side access ports. As
adhesion of uncoated beads to axons is much lower for uncoated than for
PDL-coated beads they were added at five to ten times excess.
Immunofluorescence and Line Scans
Neurons grown inmicrofluidic chambers were treated onDIV9–11 and fixed for
20 min at room temperature in 4% paraformaldehyde (PFA) in cytoskeleton
buffer (10 mM 2-(N-morpholino)ethanesulfonic acid [MES], 3 mM MgCl2,
138 mM KCl, 2 mM EGTA, 0.32 M sucrose [pH 6.1]). Neurons were washed
with PBS, permeabilized, and blocked for 30 min with 3 mg mL–1 BSA,
100mMglycine, and 0.25%Triton X-100. Coverslips were incubated overnight
at 4C with primary antibodies: rabbit anti-b-catenin (1:500, Invitrogen,
71-2700), mouse anti-synaptophysin (1:500, BioLegend, SY38), mouse anti-
GAP-43 (1:500, Invitrogen, 7B10), mouse anti-SNAP25 (1:1,000, BioLegend,
SMI 81), rabbit anti-tau (1:500, GenScript, phospho-Ser235), rabbit anti-bIII-
tubulin (1:1,000, BioLegend, Poly18020), and mouse anti-bIII-tubulin (1:500,
Abcam, TU-20). Neurons were washed with PBS and incubated with fluoro-
phore-conjugated Alexa secondary antibodies (1:200) for 1 hr at room temper-
ature. Samples were mounted with ProLong Diamond Antifade (Invitrogen),
and images were acquired in z stacks using a 633/1.3 oil objective on an
Axio-Observer.Z1 microscope equipped with an AxioCam MRm Rev. 3 cam-
era (Zeiss). Acquisition settings were kept the same for all samples in any given
experiment. Five random axonal fields containing beads were imaged per
coverslip. To quantify average fluorescence intensity at axon-beads contact
sites, a 5-mm-diameter circle around the bead center was drawn in AxioVision,
and average pixel intensity was determined inside that circle. For off-bead
values, average pixel intensity was determined in a 5-mm circle that encom-
passed axons not in proximity with beads. For each image, background fluo-
rescence intensity was determined in an area with no axons and subtracted
from all bead and off-bead values. To quantify fluorescence along the axons,
starting at the center of the bead, a three-pixel-wide line was drawn along the
axon using ImageJ. Average pixel intensity in that line was determined for
30 mm. The intensity along the last 15 mm of each segment was averaged,
and the resulting off-bead mean axonal fluorescence intensity was subtracted
from all values.
Immunoblot Analysis
Hippocampal neurons were culture in circular microfluidic chambers modified
after Park et al. (2009), in which the axon grows across a 500-mm-long micro-
groove barrier into the inner open compartment (6 mm diameter). For protein
isolation, medium was carefully removed from axonal compartment, and
axons were collected in 50 mL of RIPA buffer (50 mM Tris-HCl [pH 7.4],
150 mM NaCl, 0.25% deoxycholic acid, 1% NP-40, 1% SDS, 1 mM EDTA,
supplemented with protease and phosphatase inhibitors [Pierce]), the cham-
ber was then removed, and somatic material was collected in 100 mL of
RIPA buffer. The material from six different chambers was collected this way
using the same buffer to increase the amount of protein. 20 mL of lysate from
axons and 2 mL of lysate from cell bodies were used for western blotting. Nitro-
cellulose membrane was incubated with anti-SNAP-25 (1:1,000, BioLegend,
836304) or anti-b-III tubulin (1:10,000, BioLegend, 802001) at 4C overnight
in TBS-T with 4% milk. For detection, blots were incubated with respective
secondary antibodies (1:10,000, anti-Ms-horseradish peroxidase [HRP] or
anti-Rb-HRP, Invitrogen) and developed with 1-Shot Digital-ECL (KindleBio,
R1003), and images were taken with the KwikQuant Imager (KindleBio,
D1001).
Puromycylation and Puromycylation-Proximity Ligation Assays
To detect newly synthesized proteins, puromycin (1.8 mM, Sigma-Aldrich) or
growth medium was added to axons in compartmentalized cultures or to
dissociated neurons in regular cultures for 10–15min, depending on the exper-
iment, in the absence or presence of the protein synthesis inhibitor anisomycin
(10 mM for axons, 40 mM for dissociated cultures). After incubation, cells were
(C) Transfection of axons with SNAP25 siRNA greatly reduced the synthesis of SNAP25 at contact sites with PDL-coated beads as measured with SNAP25 puro-
PLA. Mean ± SEM of 80–103 beads in ten axonal fields per condition (n = 3 biological replicates).
(D) Experimental design for (E) and (F): hippocampal neurons were cultured and their axons selectively transfected with siRNAs and incubated with PDL-coated
beads as in (A). The neurons were fixed after 1 hr and immunostained for SNAP25 (E) or b-catenin (F).
(E) SNAP25 immunostaining in the direct vicinity of PDL-coated beads is significantly reduced in axons transfected with SNAP25 siRNA. Average fluorescence
values for 30 mm from the bead center, and the mean AUC for the 0- to 5-mm and 5- to 15-mm regions are plotted.
(F) b-catenin immunostaining in the 0- to 5-mm region is not significantly decreased in axons transfected with b-catenin siRNA. The signal intensity is increased in
the 5- to 15-mm region. Mean ± SEM of 80–100 beads (n = 3 biological replicates).
(G) Dissociated hippocampal neurons were cultured for 11 days and transfected with siRNA, and b-catenin mRNA levels were determined by RT-PCR after 48 hr.
Unpaired t tests. n.s., not significant; *p < 0.05; ***p < 0.001; ****p < 0.0001. Yellow dashed lines represent bead outline. Scale bars, 5 mm.
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washed twice with warm PBS and fixed for 20 min at room temperature in 4%
PFA in cytoskeleton buffer. Cells were washed with PBS, blocked, and per-
meabilized in 3 mg mL–1 BSA, 100 mM glycine, and 0.25% Triton X-100 and
incubated overnight at 4C with mouse anti-puromycin antibody (1:250, Milli-
pore, MABE343) and rabbit anti-SNAP25 antibody (1:250, Sigma-Aldrich,
S9684) for the puro-PLA assay. Detection of newly synthesized SNAP25
through PLA was performed according to the manufacturer’s recommenda-
tions, using rabbit PLAplus and mouse PLAminus probes and red Duolink detec-
tion reagents (Sigma-Aldrich). Before mounting with Duolink In Situ Mounting
Medium with DAPI (Sigma-Aldrich), coverslips were incubated with anti-bIII-
tubulin (1:100, Abcam, 2G10; conjugated to Alexa Fluor 488) or anti-bIII-tubulin
(1:100, Abcam, EP1569Y; Alexa Fluor 647) and anti-PSD-95 (1:50, Abcam,
EP2652Y; Alexa Fluor 488) for 1 hr at room temperature. Images were acquired
as described previously and quantified by counting the number of puromycin-
positive or PLA puncta. SNAP25 puro-PLA experiments in dissociated cultures
were imaged in a Zeiss LSM 800 confocal microscope using a 403 oil objec-
tive and Zen Blue 2.1 software.
Single-Molecule Inexpensive Fluorescence In Situ Hybridization
Oligonucleotide probeswere designed usingOligostan software (Tsanov et al.,
2016). For Snap25, we obtained 30 probes, while for Egfp we designed 15
probes due to the smaller coding sequence (Table S1). The probes were hy-
bridized to a digoxigenin-labeled FLAP oligonucleotide to create FLAP-struc-
tured duplex probes (Tsanov et al., 2016). smiFISH was performed as
described (Tsanov et al., 2016), with minor changes. On DIV10, beads were
added to the axonal compartments of hippocampal neurons grown in micro-
fluidic devices. Cells were fixed after 24 hr for 20min in 4%PFA in cytoskeleton
buffer. Coverslips were washed in PBS, permeabilized with 0.3% Triton X-100
in PBS for 5 min, and washed again with PBS. Coverslips were equilibrated at
37C in 15% formamide, 13 saline sodium citrate (SSC). Samples were incu-
bated with 10 pmol of FLAP-structured duplex probes in 50 mL of hybridization
buffer (15% formamide, 1 3 SSC, 10% dextran, 350 ng mL–1 yeast tRNA,
0.2 mg mL–1 BSA, 2 mM vanadyl ribonucleoside complex) overnight at
37C. Coverslips were washed twice with 15% formamide in 1 3 SSC for








































































































































































Figure 6. Reciprocal Effects of Local b-Catenin and SNAP25 Knockdown on Clustering
Hippocampal neurons were cultured and treated as in Figure 5D.
(A) Axons were transfected with scrambled or SNAP25 siRNA. 24 hr later, PDL-coated beads were added for 1 hr, and b-catenin clustering was determined by IF.
Fluorescence values were quantified for 30 mm starting at the bead center and mean AUC for the 0- to 5-mm and 5- to 15-mm regions are plotted.
(B) Axons were transfected with scrambled or b-catenin siRNA. 24 hr later, PDL-coated beads were added for 1 hr, and SNAP25 clustering was determined by IF.
Fluorescence values were quantified for 30 mm starting at the bead center and mean AUC for the 0- to 5-mm and 5- to 15-mm regions are plotted.
Mean ± SEM of 80–100 beads (n = of 3 different biological replicates). Unpaired t test. *p < 0.05 ****p < 0.0001. Yellow dashed lines represent bead outline. Scale
bars, 5 mm.
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Figure 7. Knockdown of Axonal SNAP25 mRNA Affects Vesicle Release of Newly Formed Synaptic Terminals
(A) Experimental design: hippocampal neurons were cultured inmicrofluidic chambers for 10 days. Axons were transfectedwith siRNAs 24 hr before adding PDL-
coated beads. 24 hr after bead incubation, cells were loaded with FM dyes and imaged.
(B) Sequential imaging and stimulation of FM4-64 puncta in scrambled or SNAP25 siRNA-treated axons at contact sites with PDL-coated beads. SNAP25 siRNA
slows vesicle release after stimulation with potassium but does not impede FM4-64 loading. Pictures were taken every 15 s, high potassiumwas added after 30 s
(legend continued on next page)
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(0.1% Tween 20) for 5 min, blocked with 3% BSA in PBS-T for 30 min, and
incubated with goat anti-digoxigenin (1:500, Vector Laboratories) overnight
at 4C. Samples were washed three times with PBS-T for 5 min and incubated
with Alexa 488 anti-goat secondary (1:1,000), and anti-bIII-tubulin was conju-
gated to Alexa-594 (Abcam, ab201740) for 1 hr at room temperature. They
were then washed with PBS and mounted with ProLong Diamond Antifade
Mountant (Invitrogen). Egfp fluorescence was used as a control for nonspecific
hybridization and subtracted from all Snap25 values. The specificity of the
Egfp probes was verified by performing smiFISH on cells transfected by a
Gfp plasmid or control (data not shown). The specificity of the Snap25 probe
was verified by RNAi in axons (Figure 4B).
siRNA Transfections
Axon-specific silencing of Snap25, ctnnb1, and pclo mRNAs was achieved
using the following siRNAs: Snap25 (NM_001270575.1) 50-CGUGUCGAA
GAAGGGAUGAACCAUA-30 and 50-UAUGGUUCAUGCCUUCUUCGACACG-
30; ctnnb1 (NM_053357.2) 50-UCUGCAUGCCCUCAUCUAGUGUCUC-30 and
50-GAGGUCGAAGAAGGCAUGAACCAUA-30; and pclo (NM_020098.1) 50-
CACCUUGCUGGUCUCUCACAUUAUU-30 and 50-AAUAAUGUGAGAGACCA
GCAAGGUG-30. Negative control siRNA was purchased from Thermo Fisher
Scientific (Stealth RNAi siRNA Negative Control Med GC Duplex #3). siRNAs
were transfected into axons of DIV10 neurons grown in microfluidic chambers
using NeuroPORTER transfection reagent (Genlantis). Final siRNA concentra-
tion was 50 nM. Beads were added 24 hr after transfection.
Real-Time RT-PCR
Total RNA from cell bodies (four chambers or 150,000 cells) and axonal com-
partments (from a minimum of six chambers) was extracted with TRIzol, and
RNA was purified using the Direct-zol RNA MiniPrep kit (Zymo Research).
Axonal RNA was eluted in 10 mL of nuclease-free water and reverse tran-
scribed to cDNA using the Superscript VILO cDNA synthesis kit. For cell
body RNA, a total of 100 ng was reverse transcribed to cDNA. Axonal cDNA
was preamplified using the TaqMan PreAmp kit, following manufacturer’s
instructions for the 14 cycles preamplification. Real-time RT-PCR was
performed with TaqMan Fast Advanced master mix in a StepOnePlus Real-
Time PCR instrument, using pre-designed TaqMan probes. Amplification con-
ditions were as follows: initial denaturing step at 95C for 10 min, 40 cycles of
denaturation at 95C for 15 s, and extension at 60C for 1min.Snap25, ctnnb1,
and pclo levels were normalized to gapdh.
FM4-64 Release Assay
After DIV11, the chamber medium was exchanged with Tyrode’s solution
(125 mM NaCl, 2 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 30 mM glucose,
25 mM HEPES [pH 7.4]), and cells were allowed to equilibrate for at least
30 min. Then, FM4-64 (15 mM, N-[3-Triethylammoniumpropyl]-4-[6-[4-[Diethy-
lamino] Phenyl] Hexatrienyl] Pyridinium Dibromide; Invitrogen) was loaded for
90 s in a high K+ solution (37 mM NaCl, 90 mM KCl, 2 mMCaCl2, 2 mMMgCl2,
30 mM glucose, 25 mM HEPES [pH 7.4]) with 10 mM CNQX (6-Cyano-7-nitro-
quinoxaline-2,3-dione disodium; Santa Cruz Biotechnology) and 50 mM DL-
AP5 (DL-2-Amino-5-phosphonovaleric acid, Santa Cruz Biotechnology). Cells
were loaded for 10moremin in Tyrode’s solution with FM4-64, CNQX, and DL-
AP5. Chambers were then briefly washed twice in low Ca2+ solution (112 mM
NaCl, 2mMKCl, 0.5 mMCaCl2, 10mMMgCl2, 30mM glucose, 25mMHEPES
[pH 7.4]) with 0.5 mM advasep-7 (Sigma-Aldrich), CNQX, and DL-AP5 and
three times in Tyrode’s solution with CNQX and DL-AP5. Unloading was
then evoked with high K+ solution. During imaging, neurons were kept in a
CO2 and humidity controlled incubation chamber at 37
C. Images were
acquired every 15 s, for a total of 4 min. High K+ was added after 30 s. The in-
tensity of FM4-64 puncta around beads was quantified over time. Relative
fluorescence values were plotted and entered in SPSS (IBM). A monoexpo-
nential fit was calculated for each individual bead data with the equation,
F =Fmax3e
time=t +Ffinal , with Fmax being the fluorescence value right before
K+ stimulation, t the exponential decay constant, and Ffinal the final plateau.
t values were plotted and compared between conditions.
Statistical Methods
Statistical analysis was performed using Prism 7 (GraphPad). The means of
two groups were compared with unpaired t tests, and the means of three
groups were compared using ANOVA with Tukey’s multiple comparison test.
The means of multiple groups with two independent variables were compared
using two-way ANOVA with Bonferroni’s multiple comparisons tests.
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